Publications

Publications from OUS - Department of Nephrology Rikshospitalet (Div SIMT)

456 publications found

Publications 2020

  1. Benoni H, Eloranta S, Dahle DO, Svensson MHS, Nordin A, Carstens J, Mjøen G, Helanterä I, Hellström V, Enblad G, Pukkala E, Sørensen SS, Lempinen M, Smedby KE (2020)
    Relative and absolute cancer risks among Nordic kidney transplant recipients - a population-based study
    Transpl Int (in press)
    DOI 10.1111/tri.13734, PubMed 32896035
  2. Bjerre A, Mjøen G, Line PD, Naper C, Reisaeter AV, Åsberg A (2020)
    Five decades with grandparent donors: The Norwegian strategy and experience
    Pediatr Transplant, 24 (6), e13751
    DOI 10.1111/petr.13751, PubMed 32485019
  3. Chandra A, Midtvedt K, Åsberg A, Eide IA (2020)
    The Authors' Reply: Placental Pathology in Pregnancies After Kidney Transplantation
    Transplantation, 104 (7), e216
    DOI 10.1097/TP.0000000000003120, PubMed 32569005
  4. Dahle DO, Mjoen G (2020)
    The Salutary Blood Pressure of a Solitary Kidney
    Am J Hypertens, 33 (3), 218-219
    DOI 10.1093/ajh/hpaa004, PubMed 31907513
  5. de Gonzalo-Calvo D, Martínez-Camblor P, Bär C, Duarte K, Girerd N, Fellström B, Schmieder RE, Jardine AG, Massy ZA, Holdaas H, Rossignol P, Zannad F, Thum T (2020)
    Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids
    Theranostics, 10 (19), 8665-8676
    DOI 10.7150/thno.46123, PubMed 32754270
  6. Eriksen BO, Palsson R, Ebert N, Melsom T, van der Giet M, Gudnason V, Indridasson OS, Inker LA, Jenssen TG, Levey AS, Solbu MD, Tighiouart H, Schaeffner E (2020)
    GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts
    J Am Soc Nephrol, 31 (7), 1602-1615
    DOI 10.1681/ASN.2020020151, PubMed 32499396
  7. Flemmen HØ, Simonsen CS, Berg-Hansen P, Moen SM, Kersten H, Heldal K, Celius EG (2020)
    Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway
    Mult Scler Relat Disord, 45, 102352 (in press)
    DOI 10.1016/j.msard.2020.102352, PubMed 32707528
  8. Gjerde A, Lillås BS, Marti HP, Reisæter AV, Vikse BE (2020)
    Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life
    Nephrol Dial Transplant, 35 (7), 1157-1163
    DOI 10.1093/ndt/gfaa001, PubMed 32040151
  9. Gjerde A, Reisæter AV, Skrunes R, Marti HP, Vikse BE (2020)
    Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life
    Clin J Am Soc Nephrol (in press)
    DOI 10.2215/CJN.04080320, PubMed 32816833
  10. Gustavsen MT, Midtvedt K, Robertsen I, Woillard JB, Debord J, Klaasen RA, Vethe NT, Bergan S, Åsberg A (2020)
    Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
    Clin Transl Sci
    DOI 10.1111/cts.12833, PubMed 32652886
  11. Gustavsen MT, Midtvedt K, Vethe NT, Robertsen I, Bergan S, Åsberg A (2020)
    Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling
    Ther Drug Monit, 42 (3), 407-414
    DOI 10.1097/FTD.0000000000000697, PubMed 31479042
  12. Haller MC, Wallisch C, Mjøen G, Holdaas H, Dunkler D, Heinze G, Oberbauer R (2020)
    Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool - a retrospective study
    Transpl Int, 33 (7), 729-739
    DOI 10.1111/tri.13580, PubMed 31970822
  13. Haugen AJ, Hallan S, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2020)
    Increased long-term risk for hypertension in kidney donors - a retrospective cohort study
    Transpl Int, 33 (5), 536-543
    DOI 10.1111/tri.13576, PubMed 31958170
  14. Klaasen RA, Bergan S, Bremer S, Hole K, Nordahl CB, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2020)
    Pharmacodynamic assessment of mycophenolic acid in resting and activated target cell population during the first year after renal transplantation
    Br J Clin Pharmacol, 86 (6), 1100-1112
    DOI 10.1111/bcp.14218, PubMed 31925806
  15. Lorentzen EM, Henriksen S, Kaur A, Kro GB, Hammarström C, Hirsch HH, Midtvedt K, Rinaldo CH (2020)
    Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
    Virol J, 17 (1), 5
    DOI 10.1186/s12985-019-1275-9, PubMed 31924245
  16. Luis-Lima S, Mas-Sanmartin C, Rodríguez-Rodríguez AE, Porrini E, Ortiz A, Gaspari F, Diaz-Martin L, Åsberg A, Jenssen T, Jiménez-Sosa A, Martinez-Ros P, Gonzalez-Bulnes A (2020)
    A Simplified Iohexol-Based Method to Measure Renal Function in Sheep Models of Renal Disease
    Biology (Basel), 9 (9)
    DOI 10.3390/biology9090259, PubMed 32878167
  17. Maggiore U, Abramowicz D, Crespo M, Mariat C, Mjoen G, Peruzzi L, Sever MS, Oniscu GC, Hilbrands L, Watschinger B (2020)
    How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion
    Nephrol Dial Transplant, 35 (6), 899-904
    DOI 10.1093/ndt/gfaa130, PubMed 32441741
  18. Nordheim E, Dahle DO, Halden T, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen TG (2020)
    Endothelial function after pancreas transplantation-A single-center observational study
    Clin Transplant, 34 (3), e13815
    DOI 10.1111/ctr.13815, PubMed 32027399

Publications 2019

  1. Antlanger M, Noordzij M, van de Luijtgaarden M, Carrero JJ, Palsson R, Finne P, Hemmelder MH, Aresté-Fosalba N, Reisæter AV, Cases A, Traynor JP, Kramar R, Massy Z, Jager KJ, Hecking M, ERA-EDTA Registry (2019)
    Sex Differences in Kidney Replacement Therapy Initiation and Maintenance
    Clin J Am Soc Nephrol, 14 (11), 1616-1625
    DOI 10.2215/CJN.04400419, PubMed 31649071
  2. Berstad AE, Brabrand K, Horneland R, Syversveen T, Haugaa H, Jenssen TG, Foss A (2019)
    Microbubble contrast-enhanced ultrasound in the vascular evaluation after pancreas transplantation: a single-center experience
    Acta Radiol, 60 (10), 1224-1231
    DOI 10.1177/0284185119828190, PubMed 30754980
  3. Bhopal A, Wium C, Reisaeter AV, Bhala N, Kumar B (2019)
    Organ donation for migrants and ethnic minorities
    Tidsskr. Nor. Laegeforen., 139 (13), 1234-1235
  4. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
    Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
    Blood Press, 29 (2), 123-134
    DOI 10.1080/08037051.2019.1684817, PubMed 31718316
  5. Boardman NT, Falck AT, Lund T, Chu X, Martin-Armas M, Norvik JV, Jenssen TG, Ytrehus K (2019)
    Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress
    Can J Physiol Pharmacol, 98 (3), 139-146
    DOI 10.1139/cjpp-2019-0024, PubMed 31518503
  6. Brovold H, Lund T, Svistounov D, Solbu MD, Jenssen TG, Ytrehus K, Zykova SN (2019)
    Crystallized but not soluble uric acid elicits pro-inflammatory response in short-term whole blood cultures from healthy men
    Sci Rep, 9 (1), 10513
    DOI 10.1038/s41598-019-46935-w, PubMed 31324844
  7. Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O et al. (2019)
    Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
    Ther Drug Monit, 41 (3), 261-307
    DOI 10.1097/FTD.0000000000000640, PubMed 31045868
  8. Chandra A, Midtvedt K, Åsberg A, Eide IA (2019)
    Immunosuppression and Reproductive Health After Kidney Transplantation
    Transplantation, 103 (11), e325-e333
    DOI 10.1097/TP.0000000000002903, PubMed 31397802
  9. Eide IA, Rashidi F, Lønning K, Oldereid NB, Reisæter AV, Åsberg A, Midtvedt K (2019)
    Contraceptive Choices and Counseling in Norwegian Female Renal Transplant Recipients
    Transplant Proc, 51 (2), 470-474
    DOI 10.1016/j.transproceed.2019.01.068, PubMed 30879570
  10. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2019)
    Author Correction: Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Sci Rep, 9 (1), 6347
    DOI 10.1038/s41598-019-42218-6, PubMed 30988313
  11. Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, Fellström B, Settembre N, Malikov S, Rossignol P, Zannad F (2019)
    Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
    Clin Kidney J, 13 (1), 116-122
    DOI 10.1093/ckj/sfz048, PubMed 32082562
  12. Gustavsen MT, Midtvedt K, Lønning K, Jacobsen T, Reisaeter AV, De Geest S, Andersen MH, Hartmann A, Åsberg A (2019)
    Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial
    Transpl Int, 32 (6), 614-625
    DOI 10.1111/tri.13412, PubMed 30770608
  13. Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, Bollerslev J, Hartmann A, Åsberg A, Jenssen T (2019)
    Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus
    Diabetes Care, 42 (6), 1067-1074
    DOI 10.2337/dc19-0093, PubMed 30862658
  14. Haugen AJ, Langberg NE, Dahle DO, Pihlstrøm H, Birkeland KI, Reisaeter A, Midtvedt K, Hartmann A, Holdaas H, Mjøen G (2019)
    Long-term risk for kidney donors with hypertension at donation - a retrospective cohort study
    Transpl Int, 32 (9), 960-964
    DOI 10.1111/tri.13443, PubMed 30983060
  15. Heldal K, Midtvedt K, Lønning K, Iversen T, Hernæs KH, Tsarpali V, Reisæter AV, Bernklev T (2019)
    Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost-utility study
    Clin Kidney J, 12 (6), 888-894
    DOI 10.1093/ckj/sfz018, PubMed 31807304
  16. Holdaas H (2019)
    People in Transplantation
    Transplantation, 103 (8), 1529-1531
    DOI 10.1097/TP.0000000000002658, PubMed 31348435
  17. Jenssen T, Hartmann A (2019)
    Post-transplant diabetes mellitus in patients with solid organ transplants
    Nat Rev Endocrinol, 15 (3), 172-188
    DOI 10.1038/s41574-018-0137-7, PubMed 30622369
  18. Jenssen TG (2019)
    Prediabetes after kidney transplantation-a reason to worry?
    Kidney Int, 96 (6), 1280-1282
    DOI 10.1016/j.kint.2019.08.008, PubMed 31759487
  19. Klaasen RA, Egeland EJ, Chan J, Midtvedt K, Svensson M, Bolstad N, Fellström B, Holdaas H, Åsberg A, Bergan S, Vethe NT, Warren DJ (2019)
    A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
    Ther Drug Monit, 41 (1), 11-18
    DOI 10.1097/FTD.0000000000000580, PubMed 30633722
  20. Legendre C, Viebahn R, Crespo M, Dor F, Gustafsson B, Samuel U, Karam V, Binet I, Aberg F, De Geest S, Moes DJAR, Tonshoff B, Oppenheimer F, Asberg A, Halleck F, Loupy A, Suesal C (2019)
    Beyond Survival in Solid Organ Transplantation: A Summary of Expert Presentations from the Sandoz 6th Standalone Transplantation Meeting, 2018
    Transplantation, 103 (9 Suppl 1), S1-S13
    DOI 10.1097/TP.0000000000002846, PubMed 31449167
  21. Lilleberg HS, Cichosz SL, Svensson M, Christensen JH, Fleischer J, Eide I, Jenssen T (2019)
    The Effect of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability in Renal Transplant Recipients: A Randomized Controlled Trial
    Nutrients, 11 (12)
    DOI 10.3390/nu11122847, PubMed 31757095
  22. Melsom T, Nair V, Schei J, Mariani L, Stefansson VTN, Harder JL, Jenssen TG, Solbu MD, Norvik JV, Looker H, Knowler WC, Kretzler M, Nelson RG, Eriksen BO (2019)
    Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians
    Am J Kidney Dis, 73 (6), 777-785
    DOI 10.1053/j.ajkd.2018.11.011, PubMed 30704883
  23. Midtvedt K, Robertsen I, Asberg A (2019)
    Generic drugs - not as similar as we think?
    Tidsskr. Nor. Laegeforen., 139 (18), 1722
  24. Mjoen G, Reisæter A, Hartmann A, Dahle DO, Holdaas H (2019)
    Regarding age-calibrated glomerular filtration rate
    Kidney Int, 95 (1), 234-235
    DOI 10.1016/j.kint.2018.10.003, PubMed 30606421
  25. Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ (2019)
    International comparison of trends in patients commencing renal replacement therapy by primary renal disease
    Nephrology (Carlton), 24 (10), 1064-1076
    DOI 10.1111/nep.13531, PubMed 30456883
  26. Thorsen IS, Bleskestad IH, Åsberg A, Hartmann A, Skadberg Ø, Brede C, Ueland T, Pasch A, Reisaeter AV, Gøransson LG (2019)
    Vitamin D as a risk factor for patient survival after kidney transplantation: A prospective observational cohort study
    Clin Transplant, 33 (5), e13517
    DOI 10.1111/ctr.13517, PubMed 30844090
  27. Tunbridge M, Holdaas H, Jardine AG (2019)
    Pulse Pressure: A Risk Factor for Renal Transplant Failure or a Useful Therapeutic Target?
    Transplantation, 103 (4), 662-663
    DOI 10.1097/TP.0000000000002441, PubMed 30188414
  28. Ussif AM, Åsberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T (2019)
    Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
    BMC Nephrol, 20 (1), 12
    DOI 10.1186/s12882-018-1171-3, PubMed 30630438
  29. Vethe NT, Gustavsen MT, Midtvedt K, Lauritsen ME, Andersen AM, Åsberg A, Bergan S (2019)
    Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients
    Ther Drug Monit, 41 (5), 607-614
    DOI 10.1097/FTD.0000000000000655, PubMed 31584926
  30. von Zur-Mühlen B, Lundgren T, Bayman L, Berne C, Bridges N, Eggerman T, Foss A, Goldstein J, Jenssen T, Jorns C, Morrison Y, Rydén M, Schwieger T, Tufveson G, Nilsson B, Korsgren O (2019)
    Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation
    Transplantation, 103 (3), 630-637
    DOI 10.1097/TP.0000000000002425, PubMed 30211831
  31. Åsberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, Porrini E, Schwartz GJ, Hartmann A, Bergan S (2019)
    Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance
    Kidney Int Rep, 5 (2), 189-198
    DOI 10.1016/j.ekir.2019.11.012, PubMed 32043033
  32. Aasebø W, Svensson M, Jenssen T, Eide IA (2019)
    Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney Transplant
    Transplant Proc, 51 (2), 466-469
    DOI 10.1016/j.transproceed.2019.01.067, PubMed 30879569

Publications 2018

  1. Abedini S, Gøransson L, Cockburn E, Kilany S, Holdaas H (2018)
    Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
    Transplant Direct, 4 (2), e338
    DOI 10.1097/TXD.0000000000000755, PubMed 29464199
  2. Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A (2018)
    Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 33 (10), 1794-1804
    DOI 10.1093/ndt/gfx355, PubMed 29361126
  3. Chandra A, Svensson M, Åsberg A, Schmidt EB, Bjerve KS, Jenssen T, Hartmann A, Ueland T, Eide IA (2018)
    Trans-fatty Acids and Survival in Renal Transplantation
    J Ren Nutr, 29 (3), 169-180
    DOI 10.1053/j.jrn.2018.08.003, PubMed 30309780
  4. Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A (2018)
    High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study
    Transpl Int, 32 (3), 257-269
    DOI 10.1111/tri.13356, PubMed 30252957
  5. Eide IA, Reinholt FP, Jenssen T, Hartmann A, Schmidt EB, Åsberg A, Bergan S, Brabrand K, Svensson M (2018)
    Effects of marine n-3 fatty acid supplementation in renal transplantation: A randomized controlled trial
    Am J Transplant, 19 (3), 790-800
    DOI 10.1111/ajt.15080, PubMed 30125457
  6. Elvebakk O, Tronstad C, Birkeland KI, Jenssen TG, Bjørgaas MR, Frøslie KF, Godang K, Kalvøy H, Martinsen ØG, Gulseth HL (2018)
    Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Sci Rep, 8 (1), 14722
    DOI 10.1038/s41598-018-33189-1, PubMed 30283093
  7. Eriksen BO, Småbrekke S, Jenssen TG, Mathisen UD, Norvik JV, Schei J, Schirmer H, Solbu MD, Stefansson VTN, Melsom T (2018)
    Office and Ambulatory Heart Rate as Predictors of Age-Related Kidney Function Decline
    Hypertension, 72 (3), 594-601
    DOI 10.1161/HYPERTENSIONAHA.118.11594, PubMed 30354758
  8. Foss S, Nordheim E, Sørensen DW, Syversen TB, Midtvedt K, Åsberg A, Dahl T, Bakkan PA, Foss AE, Geiran OR, Fiane AE, Line PD (2018)
    First Scandinavian Protocol for Controlled Donation After Circulatory Death Using Normothermic Regional Perfusion
    Transplant Direct, 4 (7), e366
    DOI 10.1097/TXD.0000000000000802, PubMed 30046656
  9. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Reisaeter AV, Seron D (2018)
    Kidney allograft subclinical rejection modulates systemic inflammation measured by C-reactive protein at 1 year after transplantation
    Clin Transplant, 32 (3), e13196
    DOI 10.1111/ctr.13196, PubMed 29380890
  10. Heldal K, Midtvedt K, Hartmann A, Reisaeter AV, Heldal TF, Bergan S, Salvador CL, Åsberg A (2018)
    Estimated glomerular filtration rate in stable older kidney transplant recipients-are present algorithms valid? A national cross-sectional cohort study
    Transpl Int, 31 (6), 629-638
    DOI 10.1111/tri.13137, PubMed 29453878
  11. Heldal TF, Ueland T, Jenssen T, Hartmann A, Reisaeter AV, Aukrust P, Michelsen A, Åsberg A (2018)
    Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study
    Transpl Int, 31 (5), 510-519
    DOI 10.1111/tri.13116, PubMed 29341300
  12. Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V (2018)
    Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry
    Am J Kidney Dis, 73 (2), 184-193
    DOI 10.1053/j.ajkd.2018.05.016, PubMed 30122544
  13. Klaasen RA, Bergan S, Bremer S, Daleq L, Andersen AM, Midtvedt K, Skauby MH, Vethe NT (2018)
    Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney Transplantation
    Ther Drug Monit, 40 (5), 558-566
    DOI 10.1097/FTD.0000000000000539, PubMed 30086087
  14. Lønning K, Heldal K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisæter AV, Line PD, Hartmann A, Midtvedt K (2018)
    Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
    Transplant Direct, 4 (4), e351
    DOI 10.1097/TXD.0000000000000770, PubMed 29707622
  15. Lønning K, Midtvedt K, Bernklev T, Brunborg C, Andersen MH, von der Lippe N, Reisaeter AV, Line PD, Hartmann A, Heldal K (2018)
    Changes in health-related quality of life in older candidates waiting for kidney transplantation
    Nephrology (Carlton), 23 (10), 948-956
    DOI 10.1111/nep.13117, PubMed 28734131
  16. Lønning K, Midtvedt K, Heldal K, Andersen MH (2018)
    Older kidney transplantation candidates' expectations of improvement in life and health following kidney transplantation: semistructured interviews with enlisted dialysis patients aged 65 years and older
    BMJ Open, 8 (6), e021275
    DOI 10.1136/bmjopen-2017-021275, PubMed 29934388
  17. Mafham MM, Staplin N, Emberson J, Haynes R, Herrington W, Reith C, Wanner C, Walker R, Cass A, Levin A, Fellström B, Jiang L, Holdaas H, Kasiske B, Wheeler DC, Landray MJ, Baigent C, SHARP Collaborative Group (2018)
    Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection
    Nephrol Dial Transplant, 33 (2), 257-264
    DOI 10.1093/ndt/gfw396, PubMed 28088776
  18. Majak GB, Reisæter AV, Weedon-Fekjær H, Henriksen T, Michelsen TM (2018)
    The Effect of Pregnancy on the Long-term Risk of Graft Loss, Cardiovascular Disease, and Death in Kidney Transplanted Women in Norway: A Retrospective Cohort Study
    Transplantation, 102 (9), e391-e396
    DOI 10.1097/TP.0000000000002167, PubMed 29528968
  19. Melsom T, Solbu MD, Schei J, Stefansson VTN, Norvik JV, Jenssen TG, Wilsgaard T, Eriksen BO (2018)
    Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population
    Kidney Int Rep, 3 (4), 817-824
    DOI 10.1016/j.ekir.2018.01.015, PubMed 29989017
  20. Mjoen G, Holdaas H (2018)
    Mid- and Long-Term Health Risks in Living Kidney Donors
    Ann Intern Med, 169 (4), 265
    DOI 10.7326/L18-0340, PubMed 30128523
  21. Nordheim E, Birkeland KI, Åsberg A, Hartmann A, Horneland R, Jenssen T (2018)
    Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study
    Eur J Endocrinol, 179 (4), 251-259
    DOI 10.1530/EJE-18-0360, PubMed 30299895
  22. Nordheim E, Horneland R, Aandahl EM, Grzyb K, Aabakken L, Paulsen V, Midtvedt K, Hartmann A, Jenssen T (2018)
    Pancreas transplant rejection episodes are not revealed by biopsies of the donor duodenum in a prospective study with paired biopsies
    Am J Transplant, 18 (5), 1256-1261
    DOI 10.1111/ajt.14658, PubMed 29316221
  23. Pedersen HL, Horvei KD, Thiyagarajan D, Norby GE, Seredkina N, Moroni G, Eilertsen GØ, Holdaas H, Strøm EH, Bakland G, Meroni PL, Rekvig OP (2018)
    Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression
    J Pathol Clin Res, 4 (3), 193-203
    DOI 10.1002/cjp2.99, PubMed 29624903
  24. Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, Dahle DO, Holdaas H, Melum E (2018)
    Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
    Am J Transplant, 19 (5), 1444-1451
    DOI 10.1111/ajt.15191, PubMed 30457209
  25. Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ (2018)
    Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (5), 540-553
    DOI 10.1111/tri.13125, PubMed 29383764
  26. Skaare H, Svensson M, Jenssen T, Åsberg A, Schmidt EB, Chandra A, Ueland T, Mollnes TE, Hartmann A, Eide IA (2018)
    Plasma n-6 Polyunsaturated Fatty Acid Levels and Survival in Renal Transplantation
    J Ren Nutr, 28 (5), 333-339
    DOI 10.1053/j.jrn.2018.02.008, PubMed 29703632
  27. Solbu MD, Kolset SO, Jenssen TG, Wilsgaard T, Løchen ML, Mathiesen EB, Melsom T, Eriksen BO, Reine TM (2018)
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study
    Atherosclerosis, 278, 166-173
    DOI 10.1016/j.atherosclerosis.2018.08.005, PubMed 30278359
  28. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
    Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
    Nephrol Dial Transplant, 33 (1), 102-112
    DOI 10.1093/ndt/gfw360, PubMed 27798199
  29. Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO (2018)
    Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population
    Kidney Int, 93 (5), 1183-1190
    DOI 10.1016/j.kint.2017.11.012, PubMed 29395334
  30. Tronstad C, Elvebakk O, Staal OM, Kalvøy H, Høgetveit JO, Jenssen TG, Birkeland KI, Martinsen ØG (2018)
    Non-invasive prediction of blood glucose trends during hypoglycemia
    Anal Chim Acta, 1052, 37-48
    DOI 10.1016/j.aca.2018.12.009, PubMed 30685040
  31. Urstad KH, Wahl AK, Engebretsen E, Larsen MH, Vidnes TK, Stenwig AGK, Simensen ØW, Nordli A, Reisaeter AV, Andersen MH (2018)
    Implementation of a new patient education programme for renal transplant recipients
    J Ren Care, 44 (2), 106-114
    DOI 10.1111/jorc.12236, PubMed 29460501
  32. Ussif A, Pihlstrøm H, Pasch A, Holdaas H, Hartmann A, Smerud K, Åsberg A (2018)
    Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
    BMC Nephrol, 19 (1), 212
    DOI 10.1186/s12882-018-1000-8, PubMed 30134956
  33. von Düring ME, Jenssen T, Bollerslev J, Godang K, Hartmann A, Åsberg A (2018)
    Arterial stiffness is associated with visceral fat mass in kidney transplanted patients-A nationwide cohort study
    Clin Transplant, 32 (8), e13341
    DOI 10.1111/ctr.13341, PubMed 29957825

Publications 2017

  1. Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM, NAVIGATOR Study Group (2017)
    Updated risk factors should be used to predict development of diabetes
    J Diabetes Complications, 31 (5), 859-863
    DOI 10.1016/j.jdiacomp.2017.02.012, PubMed 28319004
  2. Bremer S, Vethe NT, Skauby M, Kasbo M, Johansson ED, Midtvedt K, Bergan S (2017)
    NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation
    Br J Clin Pharmacol, 83 (11), 2494-2502
    DOI 10.1111/bcp.13367, PubMed 28686294
  3. de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M, ELEVATE Study Group (2017)
    Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial
    Am J Transplant, 17 (7), 1853-1867
    DOI 10.1111/ajt.14186, PubMed 28027625
  4. Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
    Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
    Prog Transplant, 27 (4), 386-391
    DOI 10.1177/1526924817732020, PubMed 29187131
  5. Eide IA, Dörje C, Svensson M, Jenssen T, Hammarstrøm C, Scott H, Bjerve KS, Christensen JH, Schmidt EB, Hartmann A, Åsberg A, Reisæter AV, Reinholt FP (2017)
    Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid Level
    J Ren Nutr, 28 (2), 118-124
    DOI 10.1053/j.jrn.2017.09.001, PubMed 29146138
  6. Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T (2017)
    Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
    Transplantation, 101 (6), 1282-1289
    DOI 10.1097/TP.0000000000001259, PubMed 27362306
  7. Eriksen BO, Stefansson VT, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
    Blood pressure and age-related GFR decline in the general population
    BMC Nephrol, 18 (1), 77
    DOI 10.1186/s12882-017-0496-7, PubMed 28245797
  8. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2017)
    High Ambulatory Arterial Stiffness Index Is an Independent Risk Factor for Rapid Age-Related Glomerular Filtration Rate Decline in the General Middle-Aged Population
    Hypertension, 69 (4), 651-659
    DOI 10.1161/HYPERTENSIONAHA.117.09020, PubMed 28223468
  9. García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV (2017)
    Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies
    Transplantation, 101 (6), 1410-1415
    DOI 10.1097/TP.0000000000001216, PubMed 27163535
  10. Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
    Should patients older than 65 years be offered a second kidney transplant?
    BMC Nephrol, 18 (1), 13
    DOI 10.1186/s12882-016-0426-0, PubMed 28077080
  11. Holdaas H, de Fijter JW, Cruzado JM, Massari P, Nashan B, Kanellis J, Witzke O, Gutierrez-Dalmau A, Turkmen A, Wang Z, Lopez P, Bernhardt P, Kochuparampil J, van der Giet M, Murbraech K, ELEVATE Study Group (2017)
    Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study
    Transplantation, 101 (10), 2612-2620
    DOI 10.1097/TP.0000000000001739, PubMed 28333860
  12. Holdaas H, Mjøen G, Jardine AG (2017)
    Belatacept: Where the BENEFITS Outweigh the Risk
    Am J Kidney Dis, 69 (5), 561-563
    DOI 10.1053/j.ajkd.2017.02.007, PubMed 28434523
  13. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    Drug Metab Dispos, 45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137
  14. Jenssen T, Hartmann A, Birkeland KI (2017)
    Long-term diabetes complications after pancreas transplantation
    Curr Opin Organ Transplant, 22 (4), 382-388
    DOI 10.1097/MOT.0000000000000436, PubMed 28598888
  15. Koefoed-Nielsen P, Weinreich I, Bengtsson M, Lauronen J, Naper C, Gäbel M, Sørensen SS, Wennberg L, Reisaeter AV, Møller BK, Nordic Kidney group and the Tissue Typing group in Scandiatransplant (2017)
    Scandiatransplant acceptable mismatch program (STAMP) a bridge to transplanting highly immunized patients
    HLA, 90 (1), 17-24
    DOI 10.1111/tan.13046, PubMed 28449350
  16. Lindahl JP, Horneland R, Nordheim E, Hartmann A, Aandahl EM, Grzyb K, Haugaa H, Kjøsen G, Åsberg A, Jenssen T (2017)
    Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy
    Am J Transplant, 18 (1), 154-162
    DOI 10.1111/ajt.14420, PubMed 28696022
  17. Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
    Transplantation, 101 (6), 1261-1267
    DOI 10.1097/TP.0000000000001274, PubMed 27467687
  18. Majak GB, Reisæter AV, Zucknick M, Lorentzen B, Vangen S, Henriksen T, Michelsen TM (2017)
    Preeclampsia in kidney transplanted women; Outcomes and a simple prognostic risk score system
    PLoS One, 12 (3), e0173420
    DOI 10.1371/journal.pone.0173420, PubMed 28319175
  19. Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
    Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
    Ann Transplant, 22, 148-155
    DOI 10.12659/aot.902330, PubMed 28321111
  20. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A (2017)
    Exposure to Mycophenolate and Fatherhood
    Transplantation, 101 (7), e214-e217
    DOI 10.1097/TP.0000000000001747, PubMed 28346297
  21. Midtvedt K, Åsberg A (2017)
    Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients
    Transplantation, 101 (1), e39
    DOI 10.1097/TP.0000000000001509, PubMed 27748704
  22. Mjøen G, Holdaas H (2017)
    Long term risk of mortality after living kidney donation
    BMJ, 357, j1770
    DOI 10.1136/bmj.j1770, PubMed 28442509
  23. Mjøen G, Holdaas H (2017)
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors"
    Kidney Int, 91 (5), 1256
    DOI 10.1016/j.kint.2017.01.034, PubMed 28407879
  24. Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K (2017)
    Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
    Lupus, 26 (8), 881-885
    DOI 10.1177/0961203316686700, PubMed 28059018
  25. Norvik JV, Schirmer H, Ytrehus K, Jenssen TG, Zykova SN, Eggen AE, Eriksen BO, Solbu MD (2017)
    Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromsø Study
    BMC Cardiovasc Disord, 17 (1), 79
    DOI 10.1186/s12872-017-0509-2, PubMed 28292262
  26. Norvik JV, Schirmer H, Ytrehus K, Storhaug HM, Jenssen TG, Eriksen BO, Mathiesen EB, Løchen ML, Wilsgaard T, Solbu MD (2017)
    Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013
    ESC Heart Fail, 4 (2), 154-161
    DOI 10.1002/ehf2.12134, PubMed 28451452
  27. Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
    Transpl Int, 30 (8), 827-840
    DOI 10.1111/tri.12973, PubMed 28436117
  28. Pippias M, Jager KJ, Caskey F, Casula A, Erlandsson H, Finne P, Heaf J, Heinze G, Hoitsma A, Kramar R, Lempinen M, Magaz A, Midtvedt K, Mumford LL, Pascual J, Prütz KG, Sørensen SS, Traynor JP, Massy ZA, Ravanan R, Stel VS (2017)
    Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association-European Dialysis and Transplant Association Registry
    Transpl Int, 31 (7), 708-719
    DOI 10.1111/tri.13103, PubMed 29210108
  29. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (5), e1006386
    DOI 10.1371/journal.ppat.1006386, PubMed 28489893
  30. Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
    Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
    PLoS Pathog, 13 (4), e1006299
    DOI 10.1371/journal.ppat.1006299, PubMed 28406982
  31. Salvador CL, Hartmann A, Åsberg A, Bergan S, Rowe AD, Mørkrid L (2017)
    Estimating Glomerular Filtration Rate in Kidney Transplant Recipients: Comparing a Novel Equation With Commonly Used Equations in this Population
    Transplant Direct, 3 (12), e332
    DOI 10.1097/TXD.0000000000000742, PubMed 29536033
  32. Schei J, Fuskevåg OM, Stefansson VTN, Solbu MD, Jenssen TG, Eriksen BO, Melsom T (2017)
    Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline
    Kidney Int Rep, 3 (3), 573-582
    DOI 10.1016/j.ekir.2017.11.020, PubMed 29854964
  33. Smerud KT, Åsberg A, Kile H, Pasch A, Dahle DO, Bollerslev J, Godang K, Hartmann A (2017)
    A rapid and sustained improvement of calcification propensity score (serum T50 ) after successful kidney transplantation: Reanalysis of a randomized controlled trial of ibandronate
    Clin Transplant, 31 (12)
    DOI 10.1111/ctr.13131, PubMed 28972673
  34. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'
    Br J Clin Pharmacol, 83 (6), 1357-1358
    DOI 10.1111/bcp.13276, PubMed 28374426
  35. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2017)
    The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation
    Br J Clin Pharmacol, 83 (7), 1457-1465
    DOI 10.1111/bcp.13248, PubMed 28146606
  36. Torres IB, Reisaeter AV, Moreso F, Âsberg A, Vidal M, Garcia-Carro C, Midtvedt K, Reinholt FP, Scott H, Castellà E, Salcedo M, Dörje C, Sellarés J, Azancot MA, Perello M, Holdaas H, Serón D (2017)
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants
    Transpl Int, 30 (11), 1119-1131
    DOI 10.1111/tri.13002, PubMed 28667664
  37. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 32 (2), 348-355
    DOI 10.1093/ndt/gfw392, PubMed 28031344
  38. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: a multidisciplinary European glossary
    Pediatr Radiol, 48 (2), 291-303
    DOI 10.1007/s00247-017-4006-7, PubMed 29138893
  39. Vivier PH, Augdal TA, Avni FE, Bacchetta J, Beetz R, Bjerre AK, Blickman J, Cochat P, Coppo R, Damasio B, Darge K, El-Ghoneimi A, Hoebeke P, Läckgren G, Leclair MD, Lobo ML, Manzoni G, Marks SD, Mattioli G, Mentzel HJ, Mouriquand P, Nevéus T, Ntoulia A, Ording-Muller LS, Oswald J et al. (2017)
    Standardization of pediatric uroradiological terms: A multidisciplinary European glossary
    J Pediatr Urol, 13 (6), 641-650
    DOI 10.1016/j.jpurol.2017.05.026, PubMed 29174378
  40. Wagner S, Apetrii M, Massy ZA, Kleber ME, Delgado GE, Scharnagel H, März W, Metzger M, Rossignol P, Jardine A, Holdaas H, Fellström B, Schmieder R, Stengel B, Zannad F, on behalf AURORA study group and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) network (2017)
    Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
    Free Radic Res, 51 (1), 14-23
    DOI 10.1080/10715762.2016.1241878, PubMed 27667446

Publications 2016

  1. Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C (2016)
    Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
    Lancet Diabetes Endocrinol, 4 (10), 829-39
    DOI 10.1016/S2213-8587(16)30156-5, PubMed 27477773
  2. Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
    Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
    Clin Transplant, 30 (7), 802-9
    DOI 10.1111/ctr.12753, PubMed 27101801
  3. Eide IA, Dahle DO, Svensson M, Hartmann A, Åsberg A, Bjerve KS, Christensen JH, Schmidt EB, Lauritsen ME, Lund K, Jenssen T (2016)
    Plasma levels of marine n-3 fatty acids and cardiovascular risk markers in renal transplant recipients
    Eur J Clin Nutr, 70 (7), 824-30
    DOI 10.1038/ejcn.2016.14, PubMed 26931669
  4. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
    Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
    Transpl Int, 29 (5), 568-78
    DOI 10.1111/tri.12757, PubMed 26875590
  5. Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
    Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
    J Ren Nutr, 27 (3), 161-168
    DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193
  6. Eriksen BO, Stefansson VTN, Jenssen TG, Mathisen UD, Schei J, Solbu MD, Wilsgaard T, Melsom T (2016)
    Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population
    Kidney Int, 90 (2), 404-410
    DOI 10.1016/j.kint.2016.03.021, PubMed 27188503
  7. Gagnum V, Stene LC, Jenssen TG, Berteussen LM, Sandvik L, Joner G, Njølstad PR, Skrivarhaug T (2016)
    Causes of death in childhood-onset Type 1 diabetes: long-term follow-up
    Diabet Med, 34 (1), 56-63
    DOI 10.1111/dme.13114, PubMed 26996105
  8. Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
    GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
    Diabetes Care, 39 (4), 617-24
    DOI 10.2337/dc15-2383, PubMed 26908914
  9. Holdaas H, De Simone P, Zuckermann A (2016)
    Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
    J Transplant, 2016, 4369574
    DOI 10.1155/2016/4369574, PubMed 27807479
  10. Jørgensen HS, Eide IA, Hartmann A, Åsberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
    Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
    J Ren Nutr, 26 (3), 196-203
    DOI 10.1053/j.jrn.2015.11.007, PubMed 26776249
  11. Kolseth IB, Reine TM, Parker K, Sudworth A, Witczak BJ, Jenssen TG, Kolset SO (2016)
    Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
    J Diabetes Complications, 31 (1), 245-252
    DOI 10.1016/j.jdiacomp.2016.06.029, PubMed 27452162
  12. Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM (2016)
    Pregnancy outcomes following maternal kidney transplantation: a national cohort study
    Acta Obstet Gynecol Scand, 95 (10), 1153-61
    DOI 10.1111/aogs.12937, PubMed 27288648
  13. Melsom T, Stefansson V, Schei J, Solbu M, Jenssen T, Wilsgaard T, Eriksen BO (2016)
    Association of Increasing GFR with Change in Albuminuria in the General Population
    Clin J Am Soc Nephrol, 11 (12), 2186-2194
    DOI 10.2215/CJN.04940516, PubMed 27683625
  14. Meyer K, Wahl AK, Bjørk IT, Wisløff T, Hartmann A, Andersen MH (2016)
    Long-term, self-reported health outcomes in kidney donors
    BMC Nephrol, 17, 8
    DOI 10.1186/s12882-016-0221-y, PubMed 26754798
  15. Miroslawska AK, Gjessing PF, Solbu MD, Fuskevåg OM, Jenssen TG, Steigen TK (2016)
    Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp
    Diabetes, 65 (8), 2164-8
    DOI 10.2337/db16-0205, PubMed 27246911
  16. Mjoen G, Reisaeter AV, Dahle DO (2016)
    HLA Mismatch and Allograft Survival
    Transplantation, 100 (9), e52
    DOI 10.1097/TP.0000000000001366, PubMed 27399204
  17. Mjøen G, Holdaas H (2016)
    Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate
    N Engl J Med, 374 (21), 2094
    DOI 10.1056/NEJMc1603007, PubMed 27223156
  18. Mjøen G, Holdaas H (2016)
    Regarding long-term outcome after kidney donation
    Transpl Int, 29 (3), 381
    DOI 10.1111/tri.12717, PubMed 26563683
  19. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 31 (1), 170
    DOI 10.1093/ndt/gfv397, PubMed 26740671
  20. Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
    Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
    Transplant Direct, 2 (11), e113
    DOI 10.1097/TXD.0000000000000627, PubMed 27826606
  21. Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, Solbu MD (2016)
    Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study
    BMC Cardiovasc Disord, 16, 85
    DOI 10.1186/s12872-016-0265-8, PubMed 27165776
  22. Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
    Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
    Am J Transplant, 17 (2), 528-533
    DOI 10.1111/ajt.13995, PubMed 27483393
  23. Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ (2016)
    Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
    Transplantation, 100 (9), 1955-62
    DOI 10.1097/TP.0000000000000962, PubMed 26588008
  24. Reine TM, Jenssen TG, Kolset SO (2016)
    Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro
    Food Nutr Res, 60, 32615
    DOI 10.3402/fnr.v60.32615, PubMed 27667774
  25. Schive SW, Foss A, Sahraoui A, Kloster-Jensen K, Hafsahl G, Kvalheim G, Lundgren T, von Zur-Mühlen B, Felldin M, Rafael E, Lempinen M, Korsgren O, Jenssen TG, Mishra V, Scholz H (2016)
    Cost and clinical outcome of islet transplantation in Norway 2010-2015
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12871, PubMed 27862341
  26. Skrunes R, Svarstad E, Reisæter AV, Marti HP, Vikse BE (2016)
    End Stage Renal Disease Predicts Increased Risk of Death in First Degree Relatives in the Norwegian Population
    PLoS One, 11 (11), e0165026
    DOI 10.1371/journal.pone.0165026, PubMed 27828975
  27. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
  28. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
  29. Stefansson VT, Schei J, Jenssen TG, Melsom T, Eriksen BO (2016)
    Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study
    BMC Nephrol, 17 (1), 172
    DOI 10.1186/s12882-016-0386-4, PubMed 27832768
  30. Størset E, Hole K, Midtvedt K, Bergan S, Molden E, Åsberg A (2016)
    Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance
    Br J Clin Pharmacol, 83 (6), 1350-1352
    DOI 10.1111/bcp.13188, PubMed 28008657
  31. Størset E, von Düring ME, Godang K, Bergan S, Midtvedt K, Åsberg A (2016)
    Prediction of Fat-Free Mass in Kidney Transplant Recipients
    Ther Drug Monit, 38 (4), 439-46
    DOI 10.1097/FTD.0000000000000305, PubMed 27019101
  32. Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
    Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
    Nephrology (Carlton), 21 (10), 821-7
    DOI 10.1111/nep.12738, PubMed 26854648
  33. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A (2016)
    Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
    Clin Transplant, 31 (1)
    DOI 10.1111/ctr.12869, PubMed 27859633

Publications 2015

  1. Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, Cullen R, Garneata L, Jager KJ, Lønning K, Metcalfe W, Morton RL, Murtagh FE, Prutz K, Robertson S, Rychlik I, Schon S, Sharp L, Speyer E, Tentori F, Caskey FJ (2015)
    How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting
    Nephrol Dial Transplant, 30 (10), 1605-14
    DOI 10.1093/ndt/gfv209, PubMed 25982327
  2. Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
    Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
    Transplantation, 99 (8), 1730-7
    DOI 10.1097/TP.0000000000000660, PubMed 25757216
  3. Dahle DO, Åsberg A, Hartmann A, Holdaas H, Bachtler M, Jenssen TG, Dionisi M, Pasch A (2015)
    Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients
    Am J Transplant, 16 (1), 204-12
    DOI 10.1111/ajt.13443, PubMed 26375609
  4. Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H (2015)
    Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study
    Transplantation, 99 (7), 1470-6
    DOI 10.1097/TP.0000000000000568, PubMed 25675199
  5. Egli A, Lisboa LF, O'Shea D, Asberg A, Mueller T, Emery V, Kumar D, Humar A (2015)
    Complexity of Host Micro-RNA Response to Cytomegalovirus Reactivation After Organ Transplantation
    Am J Transplant, 16 (2), 650-60
    DOI 10.1111/ajt.13464, PubMed 26460801
  6. Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
    Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
    Transplantation, 99 (3), 629-35
    DOI 10.1097/TP.0000000000000376, PubMed 25162478
  7. Eide IA, Halden TA, Jenssen T (2015)
    The Authors' Reply: HbA1c Is Insensitive at Month 3 After Kidney Transplantation
    Transplantation, 99 (5), e38
    DOI 10.1097/TP.0000000000000684, PubMed 25943237
  8. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
    The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation
    Clin J Am Soc Nephrol, 10 (7), 1246-56
    DOI 10.2215/CJN.11931214, PubMed 26063768
  9. Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
    Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
    Nephrol Dial Transplant, 31 (1), 160-7
    DOI 10.1093/ndt/gfv339, PubMed 26410884
  10. Jenssen T, Hartmann A (2015)
    Emerging treatments for post-transplantation diabetes mellitus
    Nat Rev Nephrol, 11 (8), 465-77
    DOI 10.1038/nrneph.2015.59, PubMed 25917553
  11. Kolseth IB, Reine TM, Vuong TT, Meen AJ, Fan Q, Jenssen TG, Grønning-Wang LM, Kolset SO (2015)
    Serglycin is part of the secretory repertoire of LPS-activated monocytes
    Immun Inflamm Dis, 3 (1), 23-31
    DOI 10.1002/iid3.47, PubMed 25866637
  12. Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
    Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
    Diabetologia, 59 (4), 844-52
    DOI 10.1007/s00125-015-3853-8, PubMed 26713324
  13. Lisboa LF, Egli A, O'Shea D, Åsberg A, Hartmann A, Rollag H, Pang XL, Tyrrell DL, Kumar D, Humar A (2015)
    Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications
    Am J Transplant, 15 (7), 1893-902
    DOI 10.1111/ajt.13222, PubMed 25833298
  14. Meen AJ, Drevon CA, Pejler G, Jenssen TG, Olstad OK, Åbrink M, Kolset SO (2015)
    Serglycin protects against high fat diet-induced increase in serum LDL in mice
    Glycoconj J, 32 (9), 703-14
    DOI 10.1007/s10719-015-9621-7, PubMed 26391682
  15. Melsom T, Schei J, Stefansson VT, Solbu MD, Jenssen TG, Mathisen UD, Wilsgaard T, Eriksen BO (2015)
    Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study
    Am J Kidney Dis, 67 (6), 841-50
    DOI 10.1053/j.ajkd.2015.10.025, PubMed 26744126
  16. Mjøen G, Holdaas H (2015)
    The authors reply:
    Kidney Int, 87 (3), 660
    DOI 10.1038/ki.2014.400, PubMed 25723634
  17. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
    Clin Transplant, 29 (8), 678-84
    DOI 10.1111/ctr.12565, PubMed 25982053
  18. Norum J, Leivestad T, Eriksen BO, Skår S, Fagerheim A, Reisæter AV (2015)
    Regional differences in renal replacement therapy in northern Norway 2000-2012
    Int J Circumpolar Health, 74, 24298
    DOI 10.3402/ijch.v74.24298, PubMed 25672881
  19. Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
    Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
    Transplantation, 99 (2), 351-9
    DOI 10.1097/TP.0000000000000583, PubMed 25594550
  20. Reine TM, Vuong TT, Rutkovskiy A, Meen AJ, Vaage J, Jenssen TG, Kolset SO (2015)
    Serglycin in Quiescent and Proliferating Primary Endothelial Cells
    PLoS One, 10 (12), e0145584
    DOI 10.1371/journal.pone.0145584, PubMed 26694746
  21. Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K (2015)
    Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed
    Transplantation, 99 (3), 528-32
    DOI 10.1097/TP.0000000000000384, PubMed 25148382
  22. Schei J, Stefansson VT, Mathisen UD, Eriksen BO, Solbu MD, Jenssen TG, Melsom T (2015)
    Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD
    Clin J Am Soc Nephrol, 11 (2), 280-6
    DOI 10.2215/CJN.07360715, PubMed 26668020
  23. Schive SW, Scholz H, Sahraoui A, Kloster-Jensen K, Hafsahl G, Korsgren O, Foss A, Jenssen TG (2015)
    Graft function 1 year after pregnancy in an islet-transplanted patient
    Transpl Int, 28 (10), 1235-9
    DOI 10.1111/tri.12596, PubMed 25903157
  24. Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
    Transplantation, 99 (4), 791-6
    DOI 10.1097/TP.0000000000000422, PubMed 25222012
  25. Solbu MD, Toft I, Løchen ML, Mathiesen EB, Eriksen BO, Melsom T, Njølstad I, Wilsgaard T, Jenssen TG (2015)
    N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population
    J Am Soc Nephrol, 27 (2), 533-42
    DOI 10.1681/ASN.2014100960, PubMed 26047791
  26. Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R (2015)
    Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies
    Nephrol Dial Transplant, 30 Suppl 1, i67-75
    DOI 10.1093/ndt/gfv008, PubMed 25694535
  27. Storhaug HM, Toft I, Norvik JV, Jenssen T, Eriksen BO, Melsom T, Løchen ML, Solbu MD (2015)
    Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study
    BMC Nephrol, 16, 210
    DOI 10.1186/s12882-015-0207-1, PubMed 26651613
  28. Størset E, Åsberg A, Skauby M, Neely M, Bergan S, Bremer S, Midtvedt K (2015)
    Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study
    Transplantation, 99 (10), 2158-66
    DOI 10.1097/TP.0000000000000708, PubMed 25886918
  29. Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
    Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
    Transplantation, 99 (1), 100-5
    DOI 10.1097/TP.0000000000000227, PubMed 24983306
  30. von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
    Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
    Transpl Int, 28 (10), 1162-71
    DOI 10.1111/tri.12606, PubMed 25970153
  31. Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO (2015)
    Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing
    J Histochem Cytochem, 63 (4), 280-92
    DOI 10.1369/0022155415568995, PubMed 25575567
  32. Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
    Impact of initial dialysis modality on mortality: a propensity-matched study
    BMC Nephrol, 16, 179
    DOI 10.1186/s12882-015-0175-5, PubMed 26519164
  33. Zykova SN, Storhaug HM, Toft I, Chadban SJ, Jenssen TG, White SL (2015)
    Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study
    Nutr J, 14, 49
    DOI 10.1186/s12937-015-0032-1, PubMed 25971955

Publications 2014

  1. Apeland T, Holdaas H, Mansoor MA (2014)
    Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity
    Clin Biochem, 47 (6), 378-82
    DOI 10.1016/j.clinbiochem.2014.02.003, PubMed 24530370
  2. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
    Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
    Ann Rheum Dis, 74 (8), 1515-21
    DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
  3. Beitland S, Os I, Sunde K (2014)
    Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy
    Scientifica (Cairo), 2014, 235215
    DOI 10.1155/2014/235215, PubMed 25587490
  4. Holdaas H, Jardine AG (2014)
    BP targets in renal transplant recipients: too high or too low?
    J Am Soc Nephrol, 25 (7), 1371-3
    DOI 10.1681/ASN.2014020177, PubMed 24627350
  5. Holdaas H, Mjoen G (2014)
    Long-term risks of kidney donation: age known
    Am J Transplant, 14 (11), 2671-2
    DOI 10.1111/ajt.12971, PubMed 25293790
  6. Holdaas H, Potena L, Saliba F (2014)
    mTOR inhibitors and dyslipidemia in transplant recipients: a cause for concern?
    Transplant Rev (Orlando), 29 (2), 93-102
    DOI 10.1016/j.trre.2014.08.003, PubMed 25227328
  7. Lindahl JP, Jenssen T, Hartmann A (2014)
    Long-term outcomes after organ transplantation in diabetic end-stage renal disease
    Diabetes Res Clin Pract, 105 (1), 14-21
    DOI 10.1016/j.diabres.2014.03.004, PubMed 24698407
  8. Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S, Åsberg A, Christensen H (2014)
    The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
    Eur J Clin Pharmacol, 70 (6), 685-93
    DOI 10.1007/s00228-014-1656-3, PubMed 24658827
  9. Midtvedt K, Heldal K (2014)
    Chronic kidney disease and the aging population
    Transplantation, 97 (11), e64
    DOI 10.1097/TP.0000000000000172, PubMed 24887750
  10. Mjøen G (2014)
    The author replies
    Kidney Int, 85 (6), 1469
    DOI 10.1038/ki.2014.91, PubMed 24875550
  11. Mjøen G, Hallan S, Dekker FW, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (3), 650
    DOI 10.1038/ki.2014.148, PubMed 25168504
  12. Mjøen G, Hallan S, Holdaas H (2014)
    The authors reply:
    Kidney Int, 85 (5), 1241-2
    DOI 10.1038/ki.2014.37, PubMed 24786884
  13. Mjøen G, Holdaas H (2014)
    The authors reply
    Kidney Int, 86 (2), 447
    DOI 10.1038/ki.2014.149, PubMed 25079028
  14. Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
    Transplantation, 97 (2), 184-8
    DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385
  15. Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
    Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
    Transplantation, 98 (11), 1219-25
    DOI 10.1097/TP.0000000000000205, PubMed 24999963
  16. Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2014)
    Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
    Diabetes Res Clin Pract, 107 (1), 46-53
    DOI 10.1016/j.diabres.2014.10.006, PubMed 25467621
  17. Reine TM, Vuong TT, Jenssen TG, Kolset SO (2014)
    Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro
    Biochim Biophys Acta, 1840 (8), 2498-505
    DOI 10.1016/j.bbagen.2014.02.002, PubMed 24513305
  18. Robertsen I, Asberg A, Granseth T, Vethe NT, Akhlaghi F, Ghareeb M, Molden E, Reier-Nilsen M, Holdaas H, Midtvedt K (2014)
    More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients
    Transplantation, 97 (12), 1266-71
    DOI 10.1097/01.TP.0000443225.66960.7e, PubMed 24521776
  19. Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014)
    Familial clustering of ESRD in the Norwegian population
    Clin J Am Soc Nephrol, 9 (10), 1692-700
    DOI 10.2215/CJN.01680214, PubMed 25092600
  20. Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
    Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
    Nephrol Dial Transplant, 29 (4), 926-33
    DOI 10.1093/ndt/gft536, PubMed 24452849
  21. Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A, Midtvedt K, Staatz CE (2014)
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
    Br J Clin Pharmacol, 78 (3), 509-23
    DOI 10.1111/bcp.12361, PubMed 25279405

Publications 2013

  1. Jenssen T (2013)
    [The body's own signaling system--now as treatment]
    Tidsskr Nor Laegeforen, 133 (23-24), 2447
    DOI 10.4045/tidsskr.13.1434, PubMed 24326489
  2. Lindahl JP, Hartmann A, Horneland R, Holdaas H, Reisæter AV, Midtvedt K, Leivestad T, Oyen O, Jenssen T (2013)
    Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
    Diabetologia, 56 (6), 1364-71
    DOI 10.1007/s00125-013-2888-y, PubMed 23549518
  3. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
    Long-term risks for kidney donors
    Kidney Int, 86 (1), 162-7
    DOI 10.1038/ki.2013.460, PubMed 24284516
  4. Reine TM, Kusche-Gullberg M, Feta A, Jenssen T, Kolset SO (2013)
    Heparan sulfate expression is affected by inflammatory stimuli in primary human endothelial cells (vol 29, pg 67, 2012)
    Glycoconjugate J., 30 (7), 733

Publications 2012

  1. Hartmann A, Jenssen T, Holdaas H (2012)
    Diabetes, chronic kidney disease and cancer risk
    Nephrol Dial Transplant, 27 (8), 3018-20
    DOI 10.1093/ndt/gfs175, PubMed 22734106
  2. Hausken J, Klingenberg O, Mørkrid L, Rollag H, Foss A, Midtvedt K (2012)
    Elevated troponin I and NT-proBNP at the time of transplantation may predict a major adverse cardiac event in the early postoperative period after renal transplantation
    Transplantation, 94 (2), e15-6
    DOI 10.1097/TP.0b013e31825b7633, PubMed 22820562
  3. Heldal K, Midtvedt K (2012)
    Doctor, should I remain on dialysis or accept the ECD kidney offered to me?
    Am J Kidney Dis, 59 (6), 748-50
    DOI 10.1053/j.ajkd.2012.03.002, PubMed 22613394
  4. Holdaas H, Jardine A (2012)
    Chronic kidney disease: Do patients with CKD benefit from lipid-lowering therapy?
    Nat Rev Nephrol, 8 (12), 684-5
    DOI 10.1038/nrneph.2012.240, PubMed 23090449
  5. Holdaas H, Midtvedt K, Åsberg A (2012)
    A drug safety evaluation of everolimus in kidney transplantation
    Expert Opin Drug Saf, 11 (6), 1013-22
    DOI 10.1517/14740338.2012.722993, PubMed 22954349
  6. Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930
  7. Valderhaug TG, Bergrem HA, Jenssen T, Hjelmesæth J (2012)
    Comment on: Chakkera et al. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care 2011;34:2141-2145
    Diabetes Care, 35 (3), e26; author reply e27
    DOI 10.2337/dc11-2046, PubMed 22355029

Publications 2011

  1. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
    Inflammation-associated graft loss in renal transplant recipients
    Nephrol Dial Transplant, 26 (11), 3756-61
    DOI 10.1093/ndt/gfr163, PubMed 21511816
  2. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
    Rosuvastatin in diabetic hemodialysis patients
    J Am Soc Nephrol, 22 (7), 1335-41
    DOI 10.1681/ASN.2010090987, PubMed 21566054
  3. Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
    Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
    Transplantation, 92 (4), 410-8
    DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773
  4. Jenssen T, Hartmann A (2011)
    Prevention and management of transplant-associated diabetes
    Expert Opin Pharmacother, 12 (17), 2641-55
    DOI 10.1517/14656566.2011.628936, PubMed 22047007
  5. Meyer K, Bjørk IT, Eide H (2011)
    Intensive care nurses' perceptions of their professional competence in the organ donor process: a national survey
    J Adv Nurs, 68 (1), 104-15
    DOI 10.1111/j.1365-2648.2011.05721.x, PubMed 21645048
  6. Midtvedt K, Holdaas H (2011)
    Belatacept: BENEFIT to the kidney?
    Am J Transplant, 11 (3), 633; author reply 634
    DOI 10.1111/j.1600-6143.2010.03411.x, PubMed 21342454
  7. Midtvedt K, Namtvedt T, Scott H, Abedini S, Rocke JC, Dørje C, Foss S, Christen U, Hagness M, Hartmann A (2011)
    Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year
    Transplant Proc, 43 (5), 2107-9
    DOI 10.1016/j.transproceed.2011.01.192, PubMed 21693337
  8. Mjøen G, Oyen O, Midtvedt K, Dahle DO, Norby G, Holdaas H (2011)
    Age, gender, and body mass index are associated with renal function after kidney donation
    Clin Transplant, 25 (6), E579-83
    DOI 10.1111/j.1399-0012.2011.01503.x, PubMed 21906171
  9. Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
    Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
    Nephrol Dial Transplant, 27 (1), 443-7
    DOI 10.1093/ndt/gfr303, PubMed 21636826
  10. Mjøen G, Stavem K, Westlie L, Midtvedt K, Fauchald P, Norby G, Holdaas H (2011)
    Quality of life in kidney donors
    Am J Transplant, 11 (6), 1315-9
    DOI 10.1111/j.1600-6143.2011.03517.x, PubMed 21486387
  11. Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
    Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
    Rheumatology (Oxford), 50 (9), 1659-64
    DOI 10.1093/rheumatology/ker186, PubMed 21624893
  12. Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
    The kidney transplantation program in Norway since 2000
    Clin Transpl, 111-8
    PubMed 22755407
  13. Valderhaug TG, Hjelmesæth J, Hartmann A, Røislien J, Bergrem HA, Leivestad T, Line PD, Jenssen T (2011)
    The association of early post-transplant glucose levels with long-term mortality
    Diabetologia, 54 (6), 1341-9
    DOI 10.1007/s00125-011-2105-9, PubMed 21409415

Publications 2010

  1. Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
    Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
    Clin J Am Soc Nephrol, 5 (4), 616-22
    DOI 10.2215/CJN.07501009, PubMed 20133490
  2. Dolgos S, Hartmann A, Isaksen GA, Simonsen S, Bjørtuft Ø, Boberg KM, Bollerslev J (2010)
    Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
    Clin Transplant, 24 (5), E145-52
    DOI 10.1111/j.1399-0012.2010.01231.x, PubMed 20236290
  3. Hirsch HH, Hartmann A (2010)
    Immunotherapy for invasive fungal infections in transplant patients: back to the future?
    Am J Transplant, 10 (8), 1719-20
    DOI 10.1111/j.1600-6143.2010.03189.x, PubMed 20636453
  4. Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
    One- and five-year follow-ups on blood pressure and renal function in kidney donors
    Transpl Int, 24 (1), 73-7
    DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180
  5. Mjøen G, Holdaas H, Pfeffer P, Line PD, Øyen O (2010)
    Minimally invasive living donor nephrectomy - introduction of hand-assistance
    Transpl Int, 23 (10), 1008-14
    DOI 10.1111/j.1432-2277.2010.01087.x, PubMed 20412538
  6. Myhre HA, Øyen O, Kårbø Ø, Midtvedt K (2010)
    Successful treatment of spontaneous kidney graft decapsulation 18 years after renal transplantation: a case report
    NDT Plus, 3 (1), 100-2
    DOI 10.1093/ndtplus/sfp148, PubMed 25949418
  7. NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of nateglinide on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1463-76
    DOI 10.1056/NEJMoa1001122, PubMed 20228402
  8. NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E et al. (2010)
    Effect of valsartan on the incidence of diabetes and cardiovascular events
    N Engl J Med, 362 (16), 1477-90
    DOI 10.1056/NEJMoa1001121, PubMed 20228403
  9. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
    [Lupus-nephritis--diagnosis and treatment]
    Tidsskr Nor Laegeforen, 130 (11), 1140-4
    DOI 10.4045/tidsskr.09.0583, PubMed 20531500
  10. Strøm EH, Reinholt FP, Midtvedt K (2010)
    JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
    Transpl Infect Dis, 13 (1), 93-4
    DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773
  11. Aasebø W, Strøm EH, Hovig T, Undset LH, Heiberg A, Jenssen T (2010)
    Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation
    NDT Plus, 3 (3), 303-305
    DOI 10.1093/ndtplus/sfq036, PubMed 28657066

Publications 2009

  1. Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
    Cerebrovascular events in renal transplant recipients
    Transplantation, 87 (1), 112-7
    DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900
  2. Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2009)
    Glucose tolerance before and after renal transplantation
    Nephrol Dial Transplant, 25 (3), 985-92
    DOI 10.1093/ndt/gfp566, PubMed 19854851
  3. Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
    Determinants of short-term changes in body composition following renal transplantation
    Scand J Urol Nephrol, 43 (1), 76-83
    DOI 10.1080/00365590802273226, PubMed 18777442
  4. Fellstrom B, Jardine A, Holdaas H, AURORA Executive Steering Comm (2009)
    Rosuvastatin in Patients Undergoing Hemodialysis REPLY
    N. Engl. J. Med., 361 (1), 94-95
  5. Midtvedt K, Bitter J, Dørje C, Bjørneklett R, Holdaas H (2009)
    Belatacept as immunosuppression in patient with recurrence of hemolytic uremic syndrome after renal transplantation
    Transplantation, 87 (12), 1901-3
    DOI 10.1097/TP.0b013e3181a991ca, PubMed 19543075
  6. Midtvedt K, Midtvedt T (2009)
    [Childhood diarrhea research in developing countries]
    Tidsskr Nor Laegeforen, 129 (15), 1484-5
    DOI 10.4045/tidsskr.09.0715, PubMed 19690601
  7. Mjøen G, Øyen O, Holdaas H, Midtvedt K, Line PD (2009)
    Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry
    Transplantation, 88 (11), 1273-9
    DOI 10.1097/TP.0b013e3181bb44fd, PubMed 19996926
  8. Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
    Experience from an active preemptive kidney transplantation program--809 cases revisited
    Transplantation, 88 (5), 672-7
    DOI 10.1097/TP.0b013e3181b27b7e, PubMed 19741464
  9. Aasebø W (2009)
    ECG-voltage in alcoholics and non-alcoholics with acute alcohol intoxication
    J Forensic Leg Med, 16 (7), 381-4
    DOI 10.1016/j.jflm.2009.01.016, PubMed 19733325
  10. Aasebø W, Hartmann A, Jenssen T (2009)
    Predictors of anemia in patients on hemodialysis
    Hemodial Int, 13 (3), 335-9
    DOI 10.1111/j.1542-4758.2009.00376.x, PubMed 19614760
  11. Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
    Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
    Nephrol Dial Transplant, 25 (4), 1289-93
    DOI 10.1093/ndt/gfp617, PubMed 19934089

Publications 2008

  1. Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T (2008)
    Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation
    Ther Drug Monit, 30 (5), 583-90
    DOI 10.1097/FTD.0b013e318187bb2f, PubMed 18728625
  2. Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
    Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
    Clin Transplant, 22 (4), 462-8
    DOI 10.1111/j.1399-0012.2008.00810.x, PubMed 18318737
  3. Holdaas H (2008)
    Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Eur Heart J, 29 (4), 425-6
    DOI 10.1093/eurheartj/ehm628, PubMed 18276612
  4. Holdaas H, Bentdal O, Pfeffer P, Mjørnstedt L, Solbu D, Midtvedt K (2008)
    Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study
    Clin Transplant, 22 (3), 366-71
    DOI 10.1111/j.1399-0012.2008.00795.x, PubMed 18279419
  5. Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A (2008)
    Pregnancy and birth after kidney donation: the Norwegian experience
    Am J Transplant, 9 (4), 820-4
    DOI 10.1111/j.1600-6143.2008.02427.x, PubMed 18853953
  6. Witczak BJ, Hartmann A, Geiran OR, Bugge JF (2008)
    Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine
    Eur J Anaesthesiol, 25 (4), 319-25
    DOI 10.1017/S0265021507003158, PubMed 18182121
  7. Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K (2008)
    Life situation and quality of life in young adult kidney transplant recipients
    Nephrol Dial Transplant, 24 (1), 304-8
    DOI 10.1093/ndt/gfn537, PubMed 18840897

Publications 2007

  1. Hjelmesaeth J (2007)
    [Increased risk of myocardial infarction following rosiglitazone?]
    Tidsskr Nor Laegeforen, 127 (13), 1809
    PubMed 17599146
  2. Hjelmesaeth J (2007)
    [Morbid obesity]
    Tidsskr Nor Laegeforen, 127 (1), 14
    PubMed 17205081
  3. Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
    The effect of ciclosporin on insulin secretion and resistance - Reply
    Nephrol. Dial. Transplant., 22 (11), 3359
  4. Midtvedt K, Bjorang O, Letting AS (2007)
    Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
    Clin Transplant, 21 (4), 571-3
    DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722
  5. Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Løvik A, Jenssen T (2007)
    Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
    Clin Transplant, 21 (2), 246-51
    DOI 10.1111/j.1399-0012.2006.00634.x, PubMed 17425753
  6. Witczak BJ, Jenssen T, Endresen K, Røislien J, Hartmann A (2007)
    Risk factors for mortality in diabetic nephropathy patients accepted for transplantation
    Transplantation, 84 (3), 356-61
    DOI 10.1097/01.tp.0000276935.31584.4c, PubMed 17700161

Publications 2006

  1. Hartmann A (2006)
    [Hypercalcemia and proteinuria]
    Tidsskr Nor Laegeforen, 126 (20), 2668
    PubMed 17063596
  2. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
    [Staging and measurement of renal function in chronic renal conditions]
    Tidsskr Nor Laegeforen, 126 (9), 1198-200
    PubMed 16670740
  3. Hartmann A, Sagedal S, Hjelmesaeth J (2006)
    The natural course of cytomegalovirus infection and disease in renal transplant recipients
    Transplantation, 82 (2 Suppl), S15-7
    DOI 10.1097/01.tp.0000230460.42558.b0, PubMed 16858268
  4. Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
    Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy
    Clin J Am Soc Nephrol, 1 (3), 575-82
    DOI 10.2215/CJN.01471005, PubMed 17699261
  5. Hjelmesaeth J, Hartmann A, Leivestad T, Holdaas H, Sagedal S, Olstad M, Jenssen T (2006)
    The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events
    Kidney Int, 69 (3), 588-95
    DOI 10.1038/sj.ki.5000116, PubMed 16395250
  6. Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
    Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
    J Am Soc Nephrol, 17 (6), 1746-54
    DOI 10.1681/ASN.2005121368, PubMed 16687626
  7. Holdaas H, Hagen E, Asberg A, Lund K, Hartman A, Vaidyanathan S, Prasad P, He YL, Yeh CM, Bigler H, Rouilly M, Denouel J (2006)
    Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients
    Int J Clin Pharmacol Ther, 44 (4), 163-71
    DOI 10.5414/cpp44163, PubMed 16625985
  8. Holdaas H, Singh D (2006)
    Fluvastatin may be similarly effective in older and younger people
    Evid Based Cardiovasc Med, 10 (1), 11-2
    DOI 10.1016/j.ebcm.2006.01.001, PubMed 16530657
  9. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials
    Int J Cardiol, 117 (1), 64-74
    DOI 10.1016/j.ijcard.2006.06.003, PubMed 16889855
  10. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2006)
    The renal safety profile of fluvastatin: results of a pooled analysis
    Ren Fail, 28 (6), 487-92
    DOI 10.1080/08860220600781260, PubMed 16928618
  11. Holdaas H, Westlie L (2006)
    [A renaissance for home hemodialysis?]
    Tidsskr Nor Laegeforen, 126 (21), 2785
    PubMed 17086216
  12. Jenssen T (2006)
    The many faces of proinsulin
    Scand J Clin Lab Invest, 66 (1), 5-6
    DOI 10.1080/00365510500474512, PubMed 16464781
  13. Midtvedt K, Brabrand K (2006)
    [Hemodynamic renal changes in right-sided heart failure]
    Tidsskr Nor Laegeforen, 126 (10), 1356; author reply 1356
    PubMed 16691279
  14. Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A (2006)
    Association between insulin resistance and endothelial dysfunction in renal transplant recipients
    Clin Transplant, 20 (2), 195-9
    DOI 10.1111/j.1399-0012.2005.00465.x, PubMed 16640526

Publications 2005

  1. Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
    New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
    Curr Diabetes Rev, 1 (1), 1-10
    DOI 10.2174/1573399052952604, PubMed 18220577
  2. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
    Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
    Nephrol Dial Transplant, 20 (11), 2311-5
    DOI 10.1093/ndt/gfi033, PubMed 16046502
  3. Holdaas H (2005)
    Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?
    Am J Cardiovasc Drugs, 5 (4), 255-69
    DOI 10.2165/00129784-200505040-00005, PubMed 15984908
  4. Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2005)
    Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study
    Am J Transplant, 5 (12), 2929-36
    DOI 10.1111/j.1600-6143.2005.01105.x, PubMed 16303007
  5. Holdaas H, Fellström B, Jardine AG, ALERT Study Group (2005)
    Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: lessons to be learnt from the assessment of Lescol in renal transplantation (ALERT) trial
    Am J Transplant, 5 (6), 1574-5
    DOI 10.1111/j.1600-6143.2005.00909.x, PubMed 15888072
  6. Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group (2005)
    Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation
    Nephrol Dial Transplant, 20 (5), 974-80
    DOI 10.1093/ndt/gfh735, PubMed 15784644
  7. Jenssen T (2005)
    The issue of measuring microalbuminuria
    Scand J Clin Lab Invest, 65 (6), 437-8
    DOI 10.1080/00365510500208308, PubMed 16179275
  8. Midtvedt K (2005)
    [Infections in immunosuppressed children]
    Tidsskr Nor Laegeforen, 125 (13), 1884; author reply 1884
    PubMed 16012580
  9. Voytovich M, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2005)
    Short-term rosiglitazone treatment in renal transplant recipients - Reply
    Nephrol. Dial. Transplant., 20 (7), 1512
  10. Witczak B, Hartmann A, Svennevig JL (2005)
    Multiple risk assessment of cardiovascular surgery in chronic renal failure patients
    Ann Thorac Surg, 79 (4), 1297-302
    DOI 10.1016/j.athoracsur.2004.09.010, PubMed 15797066

Publications 2004

  1. Hartmann A, Midtvedt K, Witczak B (2004)
    [Kidney injuries and kidney failure caused by drugs]
    Tidsskr Nor Laegeforen, 124 (21), 2765-6
    PubMed 15534671
  2. Hermann M, Asberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JL (2004)
    Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients
    Clin Pharmacol Ther, 76 (4), 388-91
    DOI 10.1016/j.clpt.2004.07.008, PubMed 15470339
  3. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T (2004)
    Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation
    Diabetologia, 47 (9), 1550-6
    DOI 10.1007/s00125-004-1499-z, PubMed 15338129
  4. Midtvedt K (2004)
    Therapeutic drug monitoring of cyclosporine
    Transplant Proc, 36 (2 Suppl), 430S-433S
    DOI 10.1016/j.transproceed.2004.01.025, PubMed 15041380
  5. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
    Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
    J Am Soc Nephrol, 15 (12), 3233-9
    DOI 10.1097/01.ASN.0000145435.80005.1E, PubMed 15579527
  6. Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2004)
    Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
    Nephrol Dial Transplant, 20 (2), 413-8
    DOI 10.1093/ndt/gfh641, PubMed 15615809

Publications 2003

  1. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003)
    A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
    Nephrol Dial Transplant, 18 (10), 2154-9
    DOI 10.1093/ndt/gfg338, PubMed 13679495
  2. Hartmann A, Fauchald P, Westlie L, Brekke IB, Holdaas H (2003)
    The risk of living kidney donation
    Nephrol Dial Transplant, 18 (5), 871-3
    DOI 10.1093/ndt/gfg069, PubMed 12686656
  3. Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A (2003)
    Determinants of insulin secretion after renal transplantation
    Metabolism, 52 (5), 573-8
    DOI 10.1053/meta.2003.50092, PubMed 12759886
  4. Hjelmesaeth J, Jenssen T, Hartmann A (2003)
    Diagnosing PTDM
    Transplantation, 75 (10), 1761
    DOI 10.1097/01.TP.0000064543.07931.F6, PubMed 12777872
  5. Holdaas H, Jardine A (2003)
    Acute renal allograft rejections, a role for statins?
    Minerva Urol Nefrol, 55 (2), 111-9
    PubMed 12847415
  6. Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T (2003)
    C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Transplantation, 76 (8), 1236-8
    DOI 10.1097/01.TP.0000085046.39523.D5, PubMed 14578761
  7. Otterstad JE, Hjelmesaeth J, Hoffstad T (2003)
    [Percutaneous coronary intervention]
    Tidsskr Nor Laegeforen, 123 (5), 685
    PubMed 12683209
  8. Schramm W, Bergrem H, Cromme P, Feest T, Borch-Johnsen K, Feldt-Rasmussen B, Landgraf R (2003)
    First referral of diabetic patients to a nephrologist
    Diabet Med, 20 (8), 689-90
    DOI 10.1046/j.1464-5491.2003.09283.x, PubMed 12873302
  9. Witczak B, Hartmann A, Leivestad T, Øyen O, Svennevig J (2003)
    Cardiovascular surgery in renal failure patients with or without subsequent renal transplantation
    Transplant Proc, 35 (2), 798-800
    DOI 10.1016/s0041-1345(03)00075-7, PubMed 12644143

Publications 2002

  1. Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
    [Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
    Tidsskr Nor Laegeforen, 122 (22), 2180-3
    PubMed 12426892
  2. Hjelmesaeth J, Carlsson PO (2002)
    Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study
    Lancet, 359 (9324), 2201-2; author reply 2203-4
    DOI 10.1016/S0140-6736(02)09074-8, PubMed 12091007
  3. Hjelmesaeth J, Jenssen T, Egeland T, Hagen M, Hartmann A (2002)
    Response to Montori et al. Post-transplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease
    Diabetes Care, 25 (9), 1667; discussion 1667-8
    DOI 10.2337/diacare.25.9.1667, PubMed 12196456
  4. Hjelmesaeth J, Jenssen T, Hartmann A (2002)
    Diagnosing PTDM
    Transplantation, 74 (4), 579
    DOI 10.1097/00007890-200208270-00027, PubMed 12352924
  5. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A (2002)
    Insulin resistance after renal transplantation
    Diabetes Care, 25 (7), 1260-1261
  6. Holdaas H, Julian D (2002)
    The use of statins after solid organ transplantation
    Nephrol Dial Transplant, 17 (8), 1537
    DOI 10.1093/ndt/17.8.1537, PubMed 12147814
  7. Midtvedt K, Hartmann A (2002)
    Hypertension after kidney transplantation: are treatment guidelines emerging?
    Nephrol Dial Transplant, 17 (7), 1166-9
    DOI 10.1093/ndt/17.7.1166, PubMed 12105236
  8. Midtvedt K, Hartmann A (2002)
    Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril"
    Transplantation, 74 (1), UNSP 0041-1337/02/7401-139/0-140

Publications 2001

  1. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P (2001)
    Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance
    Nephrol Dial Transplant, 16 (4), 829-35
    DOI 10.1093/ndt/16.4.829, PubMed 11274282
  2. Hjelmesaeth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrøm J, Mørkrid L, Egeland T, Tordarson H, Fauchald P (2001)
    Metabolic cardiovascular syndrome after renal transplantation
    Nephrol Dial Transplant, 16 (5), 1047-52
    DOI 10.1093/ndt/16.5.1047, PubMed 11328915
  3. Holdaas H, Fellström B, Holme I, Nyberg G, Fauchald P, Jardine A, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Weinreich T, Olsson AG, Pedersen TR, Benghozi R, Hartmann A, ALERT Study Group. Assessment of Lescol in Renal Transplantation (2001)
    Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data
    J Cardiovasc Risk, 8 (2), 63-71
    DOI 10.1177/174182670100800202, PubMed 11324372
  4. Holdaas H, Jardine AG, Wheeler DC, Brekke IB, Conlon PJ, Fellstrøm B, Hammad A, Holme I, Isoniemi H, Moore R, Rowe PA, Sweny P, Talbot DA, Wadstrøm J, Østraat Ø (2001)
    Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial
    Kidney Int, 60 (5), 1990-7
    DOI 10.1046/j.1523-1755.2001.00010.x, PubMed 11703619
  5. Jenssen T (2001)
    [Revised national budget and peritoneal dialysis--all that glitters is not gold]
    Tidsskr Nor Laegeforen, 121 (17), 2094
    PubMed 11875911
  6. Midtvedt K, Hartmann A, Foss A, Fauchald P, Nordal KP, Rootwelt K, Holdaas H (2001)
    Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril
    Transplantation, 72 (11), 1787-92
    DOI 10.1097/00007890-200112150-00013, PubMed 11740389
  7. Midtvedt K, Hartmann A, Holdaas H, Fauchald P (2001)
    Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial
    Clin Transplant, 15 (6), 426-31
    DOI 10.1034/j.1399-0012.2001.150611.x, PubMed 11737121
  8. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H (2001)
    Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study
    Transplantation, 72 (1), 107-11
    DOI 10.1097/00007890-200107150-00021, PubMed 11468543
  9. Reisaeter AV, Hartmann A (2001)
    Risk factors and incidence of posttransplant diabetes mellitus
    Transplant Proc, 33 (5A Suppl), 8S-18S
    DOI 10.1016/s0041-1345(01)02229-1, PubMed 11498199
  10. Witczak BJ, Asberg A, Hartmann A (2001)
    [Acute dialysis-dependent renal failure at the Rikshospital in 1998]
    Tidsskr Nor Laegeforen, 121 (10), 1216-9
    PubMed 11402747

Publications 2000

  1. Hjelmesaeth J (2000)
    [New diagnostic criteria for diabetes mellitus]
    Tidsskr Nor Laegeforen, 120 (18), 2193
    PubMed 11006749
  2. Hjelmesaeth J, Hartmann A (2000)
    Risk for posttransplant diabetes mellitus with current immunosuppressive medications
    Am J Kidney Dis, 35 (3), 562
    DOI 10.1016/s0272-6386(00)70217-4, PubMed 10692289
  3. Jindal RM, Hjelmesaeth J (2000)
    Impact and management of posttransplant diabetes mellitus
    Transplantation, 70 (11 Suppl), SS58-63
    PubMed 11152233
  4. Midtvedt K, Neumayer HH (2000)
    Management strategies for posttransplant hypertension
    Transplantation, 70 (11 Suppl), SS64-9
    PubMed 11152234
  5. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J (2000)
    Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes
    Diabetes Care, 23 (9), 1440-1
    DOI 10.2337/diacare.23.9.1440, PubMed 10977054

Publications 1999

  1. Hjelmesaeth J, Hartmann A (1999)
    Insulin resistance in patients with adult polycystic kidney disease
    Nephrol Dial Transplant, 14 (10), 2521-2
    DOI 10.1093/ndt/14.10.2521, PubMed 10528694
  2. Midtvedt K (1999)
    [Infections in renal transplant recipients in Norway]
    Tidsskr Nor Laegeforen, 119 (24), 3621-3
    PubMed 10563182
  3. Reisaeter AV (1999)
    [Kidney transplantation in Norway--a historical perspective]
    Tidsskr Nor Laegeforen, 119 (21), 3163-6
    PubMed 10522485

Publications 1998

  1. Hjelmesaeth J, Hartmann A (1998)
    [Diabetic care in general practice]
    Tidsskr Nor Laegeforen, 118 (2), 278
    PubMed 9485629
  2. Holdaas H, Hartmann A, Berg KJ, Lund K, Fauchald P (1998)
    Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy
    Nephrol Dial Transplant, 13 (12), 3096-102
    DOI 10.1093/ndt/13.12.3096, PubMed 9870472
  3. Midtvedt K (1998)
    [Clostridium difficile-associated diarrhea treated with homologous feces]
    Tidsskr Nor Laegeforen, 118 (11), 1758
    PubMed 9621767
  4. Midtvedt K, Hartmann A, Midtvedt T, Brekke IB (1998)
    Routine perioperative antibiotic prophylaxis in renal transplantation
    Nephrol Dial Transplant, 13 (7), 1637-41
    DOI 10.1093/ndt/13.7.1637, PubMed 9681704
  5. Midtvedt K, Hartmann A, Sund S (1998)
    Can a diagnosis of renal allograft rejection be based on histology alone?
    Clin Transplant, 12 (4), 300-2
    PubMed 9686323
  6. Reisaeter AV, Leivestad T, Vartdal F, Spurkland A, Fauchald P, Brekke IB, Thorsby E (1998)
    A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients
    Transplantation, 66 (4), 523-8
    DOI 10.1097/00007890-199808270-00018, PubMed 9734498
  7. Reisaeter AV, Thorsby E, Brinchmann JE (1998)
    Allospecific helper T-lymphocyte repertoire in monozygotic twins
    Scand J Immunol, 47 (4), 381-7
    DOI 10.1046/j.1365-3083.1998.00308.x, PubMed 9600321

Publications 1997

  1. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrøm J, Leivestad T, Egeland T, Fauchald P (1997)
    Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age
    Transplantation, 64 (7), 979-83
    DOI 10.1097/00007890-199710150-00008, PubMed 9381545
  2. Midtvedt K, Hartmann A, Brekke IB, Lyngdal PT, Bentdal O, Haugen G (1997)
    Successful pregnancies in a combined pancreas and renal allograft recipient and in a renal graft recipient on tacrolimus treatment
    Nephrol Dial Transplant, 12 (12), 2764-5
    DOI 10.1093/ndt/12.12.2764, PubMed 9430893
  3. Reisaeter AV, Leivestad T, Fauchald P, Brekke I, Thorsby E (1997)
    Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients
    Transplant Proc, 29 (7), 3099-100
    DOI 10.1016/s0041-1345(97)00798-7, PubMed 9365682

Publications 1996

  1. Midtvedt K, Hartmann A, Bentdal O, Brekke IB, Fauchald P (1996)
    Bilateral nephrectomy simultaneously with renal allografting does not alleviate hypertension 3 months following living-donor transplantation
    Nephrol Dial Transplant, 11 (10), 2045-9
    DOI 10.1093/oxfordjournals.ndt.a027094, PubMed 8918720
  2. Midtvedt K, Stokke ES, Hartmann A (1996)
    Successful long-term treatment of post-transplant erythrocytosis with losartan
    Nephrol Dial Transplant, 11 (12), 2495-7
    DOI 10.1093/oxfordjournals.ndt.a027224, PubMed 9017632
  3. Reisaeter AV, Brinchmann JE, Lundin KE, Thorsby E (1996)
    Monozygotic twins display differences in their allospecific cytotoxic T-cell repertoire
    Scand J Immunol, 44 (6), 638-42
    DOI 10.1046/j.1365-3083.1996.d01-357.x, PubMed 8972747
  4. Reisaeter AV, Thorsby E, Brinchmann JE (1996)
    Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells
    J Immunol Methods, 189 (1), 65-72
    DOI 10.1016/0022-1759(95)00230-8, PubMed 8576581

Publications 1995

  1. Bergrem H, Johansen KS (1995)
    Targets for glycated haemoglobin. Targets set reference points for clinic comparisons
    BMJ, 311 (6998), 189-90
    DOI 10.1136/bmj.311.6998.189c, PubMed 7613443
  2. Holdaas H, Hartmann A, Berg KJ, Langberg H, Blystad L, Fauchald P (1995)
    Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy
    J Intern Med, 237 (1), 63-71
    DOI 10.1111/j.1365-2796.1995.tb01141.x, PubMed 7830033
  3. Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P (1995)
    Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine
    Am J Cardiol, 76 (2), 102A-106A
    DOI 10.1016/s0002-9149(05)80028-1, PubMed 7604781
  4. JENSSEN T (1995)
    METHODOLOGICAL PROBLEMS IN EVALUATION OF SOCIAL REFORMS - EXEMPLIFIED BY DEINSTITUTIONALIZATION OF THE MENTALLY-RETARDED IN NORWAY
    Psychol. Rec., 45 (4), 535-563
  5. PERRIELLO G, JORDE R, NURJHAN N, STUMVOLL M, DAILEY G, JENSSEN T, BIER DM, GERICH JE (1995)
    ESTIMATION OF GLUCOSE-ALANINE-LACTATE-GLUTAMINE CYCLES IN POSTABSORPTIVE HUMANS - ROLE OF SKELETAL-MUSCLE
    Am. J. Physiol.-Endocrinol. Metab., 269 (3), E443-E450
  6. Reisaeter AV, Leivestad T, Albrechtsen D, Holdaas H, Hartmann A, Sødal G, Flatmark A, Fauchald P (1995)
    Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
    Transplantation, 60 (3), 242-8
    DOI 10.1097/00007890-199508000-00006, PubMed 7645036

Publications 1994

  1. Holdaas H, Andersson R, Fauchald P, Albrechtsen D (1994)
    [Infection in patients with organ transplants]
    Nord Med, 109 (6-7), 194-6
    PubMed 8015915
  2. JENSSEN T, NURJHAN N, PERRIELLO G, BUCCI A, TOFT I, GERICH J (1994)
    DETERMINATION OF [C-14] GLUTAMINE SPECIFIC ACTIVITY IN PLASMA
    J. Liq. Chromatogr., 17 (6), 1337-1348
  3. Reisaeter AV, Fauchald P, Leivestad T, Holdaas H, Hartmann A, Pfeffer P, Sødal G (1994)
    Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
    Transplant Proc, 26 (3), 1758
    PubMed 8030121

Publications 1993

  1. Hjelmesaeth J, Rynning S, Halvorsen E, Otterstad JE, Vatne K, Nitter-Hauge S (1993)
    [Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital]
    Tidsskr Nor Laegeforen, 113 (27), 3342-5
    PubMed 8273057
  2. Midtvedt K (1993)
    [Urinary tract infections]
    Tidsskr Nor Laegeforen, 113 (5), 618-9
    PubMed 7794286
  3. Omdal R, Gøransson L, Bergrem H (1993)
    Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis
    Clin Rheumatol, 12 (2), 283-4
    DOI 10.1007/BF02231548, PubMed 8358998

Publications 1992

  1. HAUGSTVEDT TK, VISTE A, EIDE GE, MAARTMANNMOE H, MYKING A, SOREIDE O, HANSEN O, ANDENAES K, SKJELDAL S, WESSELHOLST C, SOLHEIM K, OMLAND E, BERGAN A, GERNER T, STADAAS J, HARBITZ TB, LIAVAAG I, HOGNESTAD J, HAVIG O, LEIDAL O, UGGERUD R, NORBYE B, AASEN S, SVANE S, HOLME P et al. (1992)
    IS LAUREN HISTOPATHOLOGICAL CLASSIFICATION OF IMPORTANCE IN PATIENTS WITH STOMACH-CANCER - A NATIONAL EXPERIENCE
    Eur. J. Surg. Oncol., 18 (2), 124-130

Publications 1991

  1. Hartmann A, Holdaas H (1991)
    [Therapeutic principles in hyperkalemia]
    Tidsskr Nor Laegeforen, 111 (18), 2275-7
    PubMed 1896986
  2. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Bentdal O, Søodal G, Jervell J, Flatmark A (1991)
    Long-term glucose control following combined kidney and pancreatic transplantation
    Transplant Proc, 23 (1 Pt 2), 1656-7
    PubMed 1989322
  3. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ (1991)
    Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy
    J Intern Med, 229 (2), 163-70
    DOI 10.1111/j.1365-2796.1991.tb00325.x, PubMed 1847721
  4. Midtvedt K (1991)
    [Measurement of C-reactive protein gives valuable information on patients with various types of inflammation]
    Tidsskr Nor Laegeforen, 111 (13), 1660-1
    PubMed 2063373

Publications 1990

  1. Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark A (1990)
    Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up
    Transplant Proc, 22 (2), 655-6
    PubMed 2327010
  2. Holdaas H, Hartmann A, Talseth T, Fauchald P, Sødal G, Brekke IB, Berg KJ (1990)
    Change in intrarenal sodium reabsorption following donor nephrectomy
    Transplant Proc, 22 (1), 246
    PubMed 2309323

Publications 1989

  1. Berg KJ, Gjellestad A, Nordby G, Rootwelt K, Djøseland O, Fauchald P, Mehl A, Narverud J, Talseth T (1989)
    Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients
    Nephron, 53 (3), 218-22
    DOI 10.1159/000185747, PubMed 2677807
  2. Holdaas H, Brekke IB, Hartmann A, Talseth T, Sødal G, Jervell J, Flatmark A (1989)
    Long-term metabolic control in recipients of duct-occluded segmental pancreatic grafts
    Transplant Proc, 21 (1 Pt 3), 2854-5
    PubMed 2650384
  3. Johannessen JO, Bergrem H (1989)
    [Neuroleptic malignant syndrome]
    Tidsskr Nor Laegeforen, 109 (6), 696-7
    PubMed 2922736

Publications 1988

  1. Hartmann A, Holdaas H (1988)
    [Emergency treatment of serious hypertension]
    Tidsskr Nor Laegeforen, 108 (33), 3108-10
    PubMed 3206505
  2. Holdaas H, Hartmann A, Talseth T, Berg KJ, Fauchald P, Stenstrøm J, Djøseland O, Nordal KP, Brodwall E (1988)
    Short-term changes in renal function of the remaining kidney after donor nephrectomy
    Transplant Proc, 20 (3), 434-5
    PubMed 3381255
  3. Holdaas H, Talseth T, Berg KJ, Fauchald P, Nordal KP, Hartmann A (1988)
    Diagnostic value of peripheral plasma renin response to a single dose of captopril in suspected renal transplant artery stenosis
    Transplant Proc, 20 (3), 423-4
    PubMed 3289174

Publications 1987

  1. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1987)
    [Apudomas of the gastrointestinal tract and pancreas]
    Tidsskr Nor Laegeforen, 107 (7), 652-3, 672
    PubMed 3576560

Publications 1986

  1. Almdahl SM, Jenssen TG, Burhol PG, Giercksky KE (1986)
    Vasoactive intestinal polypeptide and somatostatin in experimental endogenous gram-negative peritonitis
    Acta Chir Scand, 152, 135-8
    PubMed 2869631
  2. Hartmann A, Langberg H, Holdaas H, Kiil F (1986)
    Glomerulotubular balance during renal sympathetic stimulation
    Acta Physiol Scand, 127 (2), 187-95
    DOI 10.1111/j.1748-1716.1986.tb07893.x, PubMed 2873711
  3. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM (1986)
    Plasma vasoactive intestinal polypeptide, insulin, gastric inhibitory polypeptide, and blood glucose in late pregnancy and during and after delivery
    Am J Obstet Gynecol, 155 (1), 126-31
    DOI 10.1016/0002-9378(86)90094-3, PubMed 3524233
  4. Holst N, Jenssen TG, Burhol PG, Jorde R, Maltau JM, Haug E (1986)
    Gut peptides in lactation
    Br J Obstet Gynaecol, 93 (2), 188-93
    DOI 10.1111/j.1471-0528.1986.tb07885.x, PubMed 2868752
  5. Hvidsten D, Jenssen TG, Bolle R, Burhol PG (1986)
    Plasma gastrointestinal regulatory peptides in exercise-induced asthma
    Eur J Respir Dis, 68 (5), 326-31
    PubMed 2874049
  6. Jenssen TG, Haukland HH, Florholmen J, Jorde R, Burhol PG (1986)
    Evidence of somatostatin as a humoral modulator of motilin release in man. A study of plasma motilin and somatostatin during intravenous infusion of somatostatin, secretin, cholecystokinin, and gastric inhibitory polypeptide
    Scand J Gastroenterol, 21 (3), 273-80
    DOI 10.3109/00365528609003076, PubMed 2872717
  7. Jenssen TG, Holst N, Burhol PG, Jorde R, Maltau JM, Vonen B (1986)
    Plasma concentrations of motilin, somatostatin and pancreatic polypeptide before, during and after parturition
    Acta Obstet Gynecol Scand, 65 (2), 153-6
    DOI 10.3109/00016348609158371, PubMed 2873707
  8. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Vonen B (1986)
    Effect of haemorrhagic shock and duodenal instillation of blood on the plasma profiles of somatostatin and motilin in pigs. A study of molecular plasma components
    Scand J Gastroenterol, 21 (3), 281-90
    DOI 10.3109/00365528609003077, PubMed 2872718
  9. Riepl R, Jenssen TG, Revhaug A, Burhol PG, Gierchksky KE, Lehnert P (1986)
    [Increase of plasma cholecystokinin by Escherichia coli endotoxin-induced shock in swine]
    Z Gastroenterol, 24 (11), 691-9
    PubMed 3544541

Publications 1985

  1. Bergrem H, Jervell J, Flatmark A (1985)
    Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients
    Kidney Int, 27 (2), 459-64
    DOI 10.1038/ki.1985.31, PubMed 3887001
  2. Burhol PG, Jenssen TG, Florholmen J, Jorde R (1985)
    Protein-binding of secretin in human plasma
    Acta Physiol Scand, 123 (3), 339-47
    DOI 10.1111/j.1748-1716.1985.tb07598.x, PubMed 4061116
  3. Burhol PG, Jenssen TG, Schulz TB, Lygren I, Jorde R (1985)
    Production and evaluation of rabbit cholecystokinin (CCK)
    Mater Med Pol, 17 (1), 34-8
    PubMed 4033220
  4. Burhol PG, Jorde R, Florholmen J, Jenssen TG, Vonen B (1985)
    A systematic approach to the preparation of 125I-labeled gastrointestinal regulatory peptides with high specific radioactivities
    Scand J Gastroenterol, 20 (4), 466-9
    DOI 10.3109/00365528509089682, PubMed 2862690
  5. Burhol PG, Lygren I, Jenssen TG, Jorde R (1985)
    Diurnal profiles of plasma cholecystokinin (CCK) and vasoactive intestinal polypeptide (VIP) in man
    Mater Med Pol, 17 (1), 30-3
    PubMed 4040993
  6. Florholmen J, Burhol PG, Jenssen TG, Jorde R (1985)
    Pharmacological effects of gastric inhibitory polypeptide, cholecystokinin, and somatostatin on the serum levels of cationic trypsin-like immunoreactivity in man
    Scand J Gastroenterol, 20 (7), 829-34
    DOI 10.3109/00365528509088830, PubMed 2864738
  7. Holdaas H, Kopp UC, DiBona GF (1985)
    Modulation of reflex renal vasoconstriction by increased endogenous renal prostaglandin synthesis
    J Pharmacol Exp Ther, 232 (3), 725-31
    PubMed 3973825
  8. Jenssen TG, Burhol PG, Jorde R (1985)
    Release of gastrointestinal regulatory peptides after a soap enema
    Scand J Gastroenterol, 20 (6), 762-6
    DOI 10.3109/00365528509089210, PubMed 2863869
  9. Jenssen TG, Revhaug A, Burhol PG, Giercksky KE, Lygren I (1985)
    The origin and fall of plasma motilin during Escherichia coli endotoxin shock in pigs
    Acta Physiol Scand, 123 (4), 399-404
    DOI 10.1111/j.1748-1716.1985.tb07606.x, PubMed 3887842
  10. Midtvedt K, Midtvedt T (1985)
    Rapid determination of antibiotic susceptibility by a disc diffusion test for urgent clinical situations
    Scand J Infect Dis, 17 (1), 131-2
    DOI 10.3109/00365548509070435, PubMed 3992201
  11. Vikse A, Holdaas H, Sejersted OM, Kiil F (1985)
    Haemodynamic conditions for renal PGE2 and renin release during alpha- and beta-adrenergic stimulation in dogs
    Acta Physiol Scand, 124 (2), 163-72
    DOI 10.1111/j.1748-1716.1985.tb07648.x, PubMed 2861715

Publications 1984

  1. Burhol PG, Jenssen TG, Jorde R, Lygren I, Johnson JA (1984)
    Plasma cholecystokinin (CCK) before and after a jejunoileal bypass operation in obese patients with reference to appetite regulation
    Int J Obes, 8 (3), 233-6
    PubMed 6746190
  2. Burhol PG, Jorde R, Jenssen TG, Lygren I, Florholmen J (1984)
    Diurnal profile of plasma somatostatin in man
    Acta Physiol Scand, 120 (1), 67-70
    DOI 10.1111/j.1748-1716.1984.tb07374.x, PubMed 6144239
  3. Burhol PG, Lygren I, Jenssen TG, Florholmen J, Jorde R (1984)
    Somatostatin release and plasma molecular somatostatin components in man
    Acta Physiol Scand, 121 (3), 223-8
    DOI 10.1111/j.1748-1716.1984.tb07450.x, PubMed 6433648
  4. Hartmann A, Holdaas H, Steen PA, Kiil F (1984)
    Evidence for bicarbonate-dependent lithium reabsorption in dog kidneys
    Acta Physiol Scand, 120 (2), 257-64
    DOI 10.1111/j.1748-1716.1984.tb00132.x, PubMed 6231805
  5. Hartmann A, Langberg H, Holdaas H, Kiil F (1984)
    Glomerular filtration rate and PCO2 as determinants of lithium reabsorption
    Acta Physiol Scand, 121 (3), 283-90
    DOI 10.1111/j.1748-1716.1984.tb07458.x, PubMed 6089506
  6. Holdaas H, DiBona GF (1984)
    Stimulatory and inhibitory reflexes from somatic receptors: effect on renin release
    Am J Physiol, 246 (6 Pt 2), R1005-10
    DOI 10.1152/ajpregu.1984.246.6.R1005, PubMed 6377915
  7. Holdaas H, DiBona GF (1984)
    On the existence of renal vasodilator nerves
    Proc Soc Exp Biol Med, 176 (4), 426-33
    DOI 10.3181/00379727-176-41893, PubMed 6463053
  8. Jenssen TG, Burhol PG, Jorde R, Florholmen J, Lygren I (1984)
    Radioimmunoassayable plasma motilin in man. Secretagogues, insulin-induced suppression, renal removal, and plasma components
    Scand J Gastroenterol, 19 (6), 717-23
    PubMed 6393315
  9. Langberg H, Hartmann A, Holdaas H, Kiil F (1984)
    Site and magnitude of the tubular inhibitory effect of expanding the extracellular volume in dogs
    Acta Physiol Scand, 122 (3), 285-98
    DOI 10.1111/j.1748-1716.1984.tb07512.x, PubMed 6516881
  10. Langård O, Holdaas H, Vikse A, Sejersted OM, Eide I (1984)
    Ouabain inhibits renin release by a direct renal haemodynamic effect
    Scand J Clin Lab Invest, 44 (6), 557-63
    DOI 10.1080/00365518409083611, PubMed 6148785
  11. Lygren I, Revhaug A, Burhol PG, Giercksky KE, Jenssen TG (1984)
    Vasoactive intestinal polypeptide and somatostatin in leucocytes
    Scand J Clin Lab Invest, 44 (4), 347-51
    DOI 10.3109/00365518409083818, PubMed 6147010
  12. Vikse A, Holdaas H, Sejersted OM, Kiil F (1984)
    Relationship between PGE2 and renin release in dog kidneys. Effects of afferent arteriolar dilation and adrenergic stimulation
    Acta Physiol Scand, 121 (3), 261-8
    DOI 10.1111/j.1748-1716.1984.tb07455.x, PubMed 6382924

Publications 1983

  1. Bergrem H, Grøttum P, Rugstad HE (1983)
    Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration
    Eur J Clin Pharmacol, 24 (3), 415-9
    DOI 10.1007/BF00610064, PubMed 6861855
  2. Bergrem H, Jervell J, Flatmark A (1983)
    Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients
    Proc Eur Dial Transplant Assoc, 20, 286-90
    PubMed 6361740
  3. BERGREM H, JERVELL J, FLATMARK A (1983)
    DIFFERENT PREDNISOLONE PHARMACOKINETICS IN CUSHINGOID AND NON-CUSHINGOID KIDNEY-TRANSPLANT PATIENTS
    P EUR DIAL TRANS, 20, 286-290
  4. Bergrem H, Opedal I (1983)
    Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding
    Scand J Gastroenterol, 18 (4), 545-9
    DOI 10.3109/00365528309181635, PubMed 6669930
  5. Bergrem H, Refvem OK (1983)
    Changes in prednisolone pharmacokinetics and protein binding during treatment with rifampicin
    Proc Eur Dial Transplant Assoc, 19, 552-7
    PubMed 6878255
  6. Bergrem H, Refvem OK (1983)
    Altered prednisolone pharmacokinetics in patients treated with rifampicin
    Acta Med Scand, 213 (5), 339-43
    DOI 10.1111/j.0954-6820.1983.tb03748.x, PubMed 6880856
  7. Bergrem H, Ritland S, Opedal I, Bergan A (1983)
    Prednisolone pharmacokinetics and protein-binding in patients with portosystemic shunt
    Scand J Gastroenterol, 18 (2), 273-6
    DOI 10.3109/00365528309181594, PubMed 6673058
  8. Holdaas H (1983)
    Adrenergic control of renin release
    J Oslo City Hosp, 33 (10-11), 111-27
    PubMed 6315904
  9. Langård O, Holdaas H, Eide I, Kiil F (1983)
    Conditions for augmentation of renin release by theophylline
    Scand J Clin Lab Invest, 43 (1), 9-14
    PubMed 6312554
  10. Osborn JL, Holdaas H, Thames MD, DiBona GF (1983)
    Renal adrenoceptor mediation of antinatriuretic and renin secretion responses to low frequency renal nerve stimulation in the dog
    Circ Res, 53 (3), 298-305
    DOI 10.1161/01.res.53.3.298, PubMed 6349846
  11. Vikse A, Holdaas H, Hartmann A, Kiil F (1983)
    Segmental distribution of vascular resistances during ureteral occlusion. The vasoconstrictive effects of angiotensin and CaCl2 differ from those of catecholamines and renal nerve stimulation
    Acta Physiol Scand, 119 (2), 147-58
    DOI 10.1111/j.1748-1716.1983.tb07320.x, PubMed 6140816
  12. Vikse A, Holdaas H, Sejersted OM, Eide I, Kiil F (1983)
    Prostaglandin E2 and renin release response to dilation of afferent arterioles and during alpha- and beta-adrenergic stimulation
    Acta Med Scand Suppl, 677, 44-7
    DOI 10.1111/j.0954-6820.1984.tb08627.x, PubMed 6322531

Publications 1982

  1. Bergrem H, Jervell J, Solheim DM, Flatmark A (1982)
    Prognostic value of renal vein renin determination in suspected renovascular hypertension
    Acta Med Scand, 211 (5), 387-91
    DOI 10.1111/j.0954-6820.1982.tb01967.x, PubMed 6126071
  2. BERGREM H, REFVEM OK (1982)
    CHANGES IN PREDNISOLONE PHARMACOKINETICS AND PROTEIN-BINDING DURING TREATMENT WITH RIFAMPICIN
    P EUR DIAL TRANS, 19, 552-557
  3. Burhol PG, Jenssen TG, Lygren I, Schulz TB, Jorde R, Waldum HL (1982)
    Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man
    Digestion, 23 (3), 156-68
    DOI 10.1159/000198723, PubMed 7106417
  4. Holdaas H, Langaard O, Eide I, Kiil F (1982)
    Conditions for enhancement of renin release by isoproterenol, dopamine, and glucagon
    Am J Physiol, 242 (3), F267-73
    DOI 10.1152/ajprenal.1982.242.3.F267, PubMed 7039349
  5. Midtvedt T, Midtvedt K (1982)
    Sport and infection
    Scand J Soc Med Suppl, 29, 241-4
    PubMed 6958046
  6. MIDTVEDT T, MIDTVEDT K (1982)
    SPORT AND INFECTION
    Scand. J. Soc. Med. (29), 241-244

Publications 1981

  1. BERGREM H, DJOSELAND O, JERVELL J, RUGSTAD HE (1981)
    ABSORPTION OF PREDNISOLONE .1. THE EFFECT OF FASTING, FOOD, AND FOOD COMBINED WITH ANTACIDS
    Scand. J. Urol. Nephrol. (64), 167-173
  2. Bergrem H, Djøseland O, Jervell J, Rugstad HE (1981)
    Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids
    Scand J Urol Nephrol Suppl, 64, 167-73
    PubMed 6959258
  3. BERGREM H, JAKOBSEN A, FLATMARK A (1981)
    PREDNISOLONE IN RENAL-TRANSPLANTATION - A COMPARISON BETWEEN 2 DOSAGE REGIMES
    Scand. J. Urol. Nephrol. (64), 174-178
  4. Bergrem H, Jakobsen A, Flatmark A (1981)
    Prednisolone in renal transplantation: a comparison between two dosage regimes
    Scand J Urol Nephrol Suppl, 64, 174-8
    PubMed 6755677
  5. Holdaas H, DiBona GF, Kiil F (1981)
    Effect of low-level renal nerve stimulation on renin release from nonfiltering kidneys
    Am J Physiol, 241 (2), F156-61
    DOI 10.1152/ajprenal.1981.241.2.F156, PubMed 7023249
  6. Holdaas H, Langård O, Eide I, Kiil F (1981)
    Mechanism of renin release during renal nerve stimulation in dogs
    Scand J Clin Lab Invest, 41 (7), 617-25
    DOI 10.3109/00365518109090506, PubMed 7041238
  7. Jenssen TG, Waldum HL, Burhol PG, Straume BK (1981)
    [The diagnosis of peptic ulcer and gastric cancer in gastroscopy case material]
    Tidsskr Nor Laegeforen, 101 (12), 706-9
    PubMed 7245155
  8. Jorde R, Burhol PG, Schulz TB, Waldum HL, Lygren I, Jenssen T, Myhre ES (1981)
    The effect of a 34-h fast on the meal-induced rises in plasma GIP, serum insulin, and blood glucose in man
    Scand J Gastroenterol, 16 (1), 109-12
    PubMed 7015476
  9. Jorde R, Waldum HL, Burhol PG, Lygren I, Schulz TB, Florholmen J, Jenssen TG (1981)
    The effect of somatostatin on fasting and postprandial plasma GIP, serum insulin, and blood glucose in man
    Scand J Gastroenterol, 16 (1), 113-9
    PubMed 6112787
  10. Langberg H, Mathisen O, Holdaas H, Kiil F (1981)
    Filtered bicarbonate and plasma pH as determinants of renal bicarbonate reabsorption
    Kidney Int, 20 (6), 780-8
    DOI 10.1038/ki.1981.211, PubMed 6801371
  11. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for stimulation of renin release by cyclic AMP in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 535-42
    DOI 10.3109/00365518109090495, PubMed 6278577
  12. Langård O, Holdaas H, Eide I, Kiil F (1981)
    Conditions for humoral alpha-adrenoceptor stimulation of renin release in anaesthetized dogs
    Scand J Clin Lab Invest, 41 (6), 527-34
    DOI 10.3109/00365518109090494, PubMed 6278576
  13. PAPE J, JERVELL J, ANKER E, BERGREM H, DAHLE K, LEIVESTAD T, MYRSETH L, THAULOW E, URVING H, VANDERLIPPE A (1981)
    BLOOD-PRESSURE AND PULSE RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA DURING NON-SELECTIVE AND SELECTIVE BETA-BLOCKADE
    Acta Med. Scand. (645), 105-108
  14. Pape J, Jervell J, Anker E, Bergrem H, Dahle K, Leivestad T, vd Lippe A, Myrseth L, Thaulow E, Urving H (1981)
    Blood pressure and pulse response to insulin-induced hypoglycemia during non-selective and selective beta-blockade
    Acta Med Scand Suppl, 645, 105-8
    DOI 10.1111/j.0954-6820.1981.tb02608.x, PubMed 6112844

Publications 1980

  1. Bergrem H, Jervell J, Brodwall EK, Flatmark A, Mellbye O (1980)
    Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant
    Am J Med, 68 (1), 54-8
    DOI 10.1016/0002-9343(80)90165-5, PubMed 6985766
  2. Midtvedt T, Midtvedt K (1980)
    [Athletics and infections]
    Tidsskr Nor Laegeforen, 100 (12B), 859-62
    PubMed 7404535
  3. Røyset PM, Jenssen TG, Burhol PG (1980)
    [Crohn's disease. Tromsø-material from the period 1974-1978]
    Tidsskr Nor Laegeforen, 100 (16), 1068-70
    PubMed 7414587

Publications 1979

  1. Jenssen TG, Røyset P, Burhol P (1979)
    [Ulcerative colitis. A Tromsø series, 1974-1977]
    Tidsskr Nor Laegeforen, 99 (3), 149-52
    PubMed 419493
  2. Mathisen O, Holdaas H, Kiil F (1979)
    Re-examination of the dose-reponse relationship for the renal effect of acetozolamide
    Scand J Clin Lab Invest, 39 (4), 297-301
    DOI 10.3109/00365517909106112, PubMed 523981
  3. Mathisen O, Monclair T, Holdaas H, Kiil F (1979)
    To what extent does acetazolamide inhibit renal bicarbonate reabsorption?
    Scand J Clin Lab Invest, 39 (4), 293-5
    DOI 10.3109/00365517909106111, PubMed 118512

Publications 1978

  1. Bergrem H, Flatmark A, Simonsen S (1978)
    Dialysis fistulas and cardiac failure
    Acta Med Scand, 204 (3), 191-3
    DOI 10.1111/j.0954-6820.1978.tb08423.x, PubMed 696419
  2. Bergrem H, Leivestad T (1978)
    Dialysis death and increased free fatty acids
    Lancet, 2 (8100), 1160
    DOI 10.1016/s0140-6736(78)92328-0, PubMed 82729
  3. Bohmer T, Bergrem H, Eiklid K (1978)
    Carnitine deficiency induced during intermittent haemodialysis for renal failure
    Lancet, 1 (8056), 126-8
    DOI 10.1016/s0140-6736(78)90422-1, PubMed 87556
  4. Mathisen O, Monclair T, Holdaas H, Kiil F (1978)
    Bicarbonate as mediator of proximal tubular NaCl reabsorption and glomerulotubular balance
    Scand J Clin Lab Invest, 38 (1), 7-17
    DOI 10.3109/00365517809108396, PubMed 415348
  5. Sejersted OM, Holdaas H, Monclair T (1978)
    Functional differences of ouabain and ethacrynic acid on renal potassium metabolism in dogs
    Scand J Clin Lab Invest, 38 (7), 603-14
    DOI 10.3109/00365517809102426, PubMed 152453

Publications 1977

  1. BOHMER T, BERGREM H, EIKLID K (1977)
    CARNITINE DEFICIENCY INDUCED DURING INTERMITTENT HEMODIALYSIS FOR RENAL-FAILURE
    Lancet, 1 (8056), 127-128

Publications 1968

  1. Poulsen PA, Norby G, Esmann V (1968)
    [Purulent meningitis. A survey of 270 patients from the period 1938-1967]
    Nord Med, 79 (16), 519-23
    PubMed 5657637

Publications 1966

  1. Petersen ES, Norby G (1966)
    A comparison between two techniques of smallpox vaccination
    Dan Med Bull, 13 (6), 168-9
    PubMed 5927702

Publications 1959

  1. POULSEN PA, NORBY G (1959)
    Tetanus: An analysis of 40 cases treated during the period 1939-1959
    Dan Med Bull, 6, 223-7
    PubMed 14434515

Publications 1955

  1. BASTRUP-MADSEN P, NØRBY G (1955)
    Pneumococcal meningitis; mastoidectomy adjunctive to antibiotic treatment
    Acta Med Scand, 151 (2), 135-49
    DOI 10.1111/j.0954-6820.1955.tb10275.x, PubMed 14349632

Publications 1952

  1. BASTRUP-MADSEN P, NØRBY G (1952)
    [Antibiotic therapy of staphylococcus septicemia]
    Nord Med, 47 (7), 201-3
    PubMed 14910973
  2. NØRBY G (1952)
    [Hemoculture]
    Nord Med, 47 (7), 224
    PubMed 14910983